TY 2022 Form 990

(A) Name and title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)	(E) Reportable compensation from related organizations (W-2/1099-MISC/1099-NEC)	(F) Estimated amount of other compensation from the organization and related organizations
(1) Charles D Henderson Effective May 1...................................................................... Chief Executive Officer	37.00 ................. 000.50		X			610,335	195,079
(2) Robert A Gabbay...................................................................... Chief Scientific Medical Officer	37.50 .................			X		579,883	69,031
(3) Charlotte M Carter...................................................................... Chief Financial Administrative Officer	37.00 ................. 000.50		X			390,761	42,398
(4) Sean C McDonough...................................................................... Senior Vice President General Counsel	37.50 .................				X	228,497	23,304
(5) Alana Seger...................................................................... SVP Field Revenue Operations	37.50 .................			X		188,127	37,348
(6) Lisa A Murdock...................................................................... Chief Advocacy Officer	37.50 .................				X	192,840	23,195
(7) Kelly A Mueller...................................................................... Senior Vice President, Strategy	37.50 .................				X	197,406	9,421
(8) Nuha El Sayed...................................................................... Vice President, Health Care Improvement	37.50 .................				X	202,489	2,009
(9) Laura B Hieronymus...................................................................... Vice President, Health Care Programs	37.50 .................				X	192,033	11,343
(10) Christopher K Ralston JD...................................................................... Chair of the Board	6.00 ................. 000.20	X	X			0	0
(11) Guillermo Umpierrez MD CDE...................................................................... President, Medicine Science	6.00 ................. 000.20	X	X			0	0
(12) Otis W Kirksey PharmD RPh CDE BC-AD...................................................................... President, Health Care Education	6.00 ................. 000.20	X	X			0	0
(13) Marshall Case...................................................................... Secretary-Treasurer	6.00 ................. 000.20	X	X			0	0
(14) Rone Luczynski...................................................................... Chair of the Board-Elect	2.00 ................. 000.20	X	X			0	0
(15) Rodica Pop-Busui MD PhD...................................................................... President-Elect, Medicine Science	2.00 ................. 000.20	X	X			0	0
(16) Janet Brown-Friday RN MSN MPH...................................................................... President-Elect, Health Care Education	2.00 ................. 000.20	X	X			0	0
(17) Todd F Brown PMP...................................................................... Secretary/Treasurer-Elect	2.00 ................. 000.20	X	X			0	0

(A) Name and business address	(B) Description of services	(C) Compensation
BOATHOUSE GROUP INC 260 Charles Street 4th Floor Waltham,MA02453	Marketing and Communications	1,077,875
VENN STRATEGIES 1341 G Street NW 6th Floor Washington,DC20005	Consulting	973,803
PROSONO LLC 1120 Lincoln St Suite 704 Denver,CO80203	Project Management Services	865,168
BLACKBAUD INC 11501 Domain Drive Suite 220 Austin,TX78758	Constituent Records Application Technical Services	460,729
CHAPMAN CUBINE ALLEN & HUSSEY INC 2000 N 15th Street Suite 550 Arlington,VA22201	Fundraising Counsel	424,800
2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization 28

- TIN:

SCHEDULE A
(Form 990)

Department of the Treasury
Internal Revenue Service

Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow

Attach to Form 990 or Form 990-EZ.
right arrow

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2022

Open to Public
Inspection

Name of the organization

American Diabetes Association

Employer identification number

13-1623888

Part I

Reason for Public Charity Status (All organizations must complete this part.) See instructions.

The organization is not a private foundation because it is: (For lines 1 through 12, check only one box.)

A church, convention of churches, or association of churches described in section 170(b)(1)(A)(i).

A school described in section 170(b)(1)(A)(ii). (Attach Schedule E (Form 990).)

A hospital or a cooperative hospital service organization described in section 170(b)(1)(A)(iii).

A medical research organization operated in conjunction with a hospital described in section 170(b)(1)(A)(iii). Enter the hospital's name, city, and state:

An organization operated for the benefit of a college or university owned or operated by a governmental unit described in section 170(b)(1)(A)(iv). (Complete Part II.)

A federal, state, or local government or governmental unit described in section 170(b)(1)(A)(v).

An organization that normally receives a substantial part of its support from a governmental unit or from the general public described in section 170(b)(1)(A)(vi). (Complete Part II.)

A community trust described in section 170(b)(1)(A)(vi). (Complete Part II.)

An agricultural research organization described in 170(b)(1)(A)(ix) operated in conjunction with a land-grant college or university or a non-land grant college of agriculture. See instructions. Enter the name, city, and state of the college or university:

An organization that normally receives: (1) more than 33 1/3% of its support from contributions, membership fees, and gross receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 33 1/3% of its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)

An organization organized and operated exclusively to test for public safety. See section 509(a)(4).

An organization organized and operated exclusively for the benefit of, to perform the functions of, or to carry out the purposes of one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2). See section 509(a)(3). Check the box on lines 12a through 12d that describes the type of supporting organization and complete lines 12e, 12f, and 12g.

Type I. A supporting organization operated, supervised, or controlled by its supported organization(s), typically by giving the supported organization(s) the power to regularly appoint or elect a majority of the directors or trustees of the supporting organization. You must complete Part IV, Sections A and B.

Type II. A supporting organization supervised or controlled in connection with its supported organization(s), by having control or management of the supporting organization vested in the same persons that control or manage the supported organization(s). You must complete Part IV, Sections A and C.

Type III functionally integrated. A supporting organization operated in connection with, and functionally integrated with, its supported organization(s) (see instructions). You must complete Part IV, Sections A, D, and E.

Type III non-functionally integrated. A supporting organization operated in connection with its supported organization(s) that is not functionally integrated. The organization generally must satisfy a distribution requirement and an attentiveness requirement (see instructions). You must complete Part IV, Sections A and D, and Part V.

Check this box if the organization received a written determination from the IRS that it is a Type I, Type II, Type III functionally integrated, or Type III non-functionally integrated supporting organization.

Enter the number of supported organizations ...............................

Provide the following information about the supported organization(s).

(i) Name of supported organization	(ii) EIN	(iv) Is the organization listed in your governing document?		(v) Amount of monetary support (see instructions)	(vi) Amount of other support (see instructions)
(i) Name of supported organization	(ii) EIN	Yes	No	(v) Amount of monetary support (see instructions)	(vi) Amount of other support (see instructions)


Total

For Paperwork Reduction Act Notice, see the Instructions for
Form 990 or 990-EZ.

Cat. No. 11285F

Schedule A (Form 990) 2022

Page 2

Part II

Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization failed to qualify under the tests listed below, please complete Part III.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2018	(b) 2019	(c) 2020	(d) 2021	(e) 2022	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") ..	118,306,745	108,955,331	88,149,776	113,184,567	93,952,438	522,548,857
2	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....
3	The value of services or facilities furnished by a governmental unit to the organization without charge..
4	Total. Add lines 1 through 3	118,306,745	108,955,331	88,149,776	113,184,567	93,952,438	522,548,857
5	The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) ..						34,043,883
6	Public support. Subtract line 5 from line 4.						488,504,974

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2018	(b) 2019	(c) 2020	(d) 2021	(e) 2022	(f) Total
7	Amounts from line 4..	118,306,745	108,955,331	88,149,776	113,184,567	93,952,438	522,548,857
8	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...	4,492,015	3,352,336	2,566,585	3,236,138	3,502,605	17,149,679
9	Net income from unrelated business activities, whether or not the business is regularly carried on..
10	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.)..	2,730					2,730
11	Total support. Add lines 7 through 10						539,701,266

Gross receipts from related activities, etc. (see instructions) ..................

140,505,347

First 5 years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here ........................................ right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2022 (line 6, column (f) divided by line 11, column (f)) .........

90.510 %

Public support percentage for 2020 Schedule A, Part II, line 14 ...............

91.260 %

16a

33 1/3% support test—2022. If the organization did not check the box on line 13, and line 14 is 33 1/3% or more, check this box
and stop here. The organization qualifies as a publicly supported organization ....................... right arrow

33 1/3% support test—2021. If the organization did not check a box on line 13 or 16a, and line 15 is 33 1/3% or more, check this
box and stop here. The organization qualifies as a publicly supported organization ..................... right arrow

17a

10%-facts-and-circumstances test—2022. If the organization did not check a box on line 13, 16a, or 16b, and line 14 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain in Part VI how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported organization ............ right arrow

10%-facts-and-circumstances test—2021. If the organization did not check a box on line 13, 16a, 16b, or 17a, and line 15 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain in Part VI how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported organization ............ right arrow

Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow

Schedule A (Form 990) 2022

Page 3

Part III

Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 10 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2018	(b) 2019	(c) 2020	(d) 2021	(e) 2022	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .
2	Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose
3	Gross receipts from activities that are not an unrelated trade or business under section 513 .....
4	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...
5	The value of services or facilities furnished by a governmental unit to the organization without charge
6	Total. Add lines 1 through 5
7a	Amounts included on lines 1, 2, and 3 received from disqualified persons
b	Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.
c	Add lines 7a and 7b..
8	Public support. (Subtract line 7c from line 6.)

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2018	(b) 2019	(c) 2020	(d) 2021	(e) 2022	(f) Total
9	Amounts from line 6...
10a	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..
b	Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.
c	Add lines 10a and 10b.
11	Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on.
12	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..
13	Total support. (Add lines 9, 10c, 11, and 12.)..

First 5 years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here................................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2022 (line 8, column (f) divided by line 13, column (f)) .........

Public support percentage from 2021 Schedule A, Part III, line 15 ...............

Section D. Computation of Investment Income Percentage

Investment income percentage for 2022 (line 10c, column (f) divided by line 13, column (f)) ......

Investment income percentage from 2021 Schedule A, Part III, line 17 .............

19a

33 1/3% support tests-2022. If the organization did not check the box on line 14, and line 15 is more than 33 1/3%, and line 17 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ....... right arrow

33 1/3% support tests—2021. If the organization did not check a box on line 14 or line 19a, and line 16 is more than 33 1/3% and line 18 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ..... right arrow

Private foundation. If the organization did not check a box on line 14, 19a, or 19b, check this box and see instructions .... right arrow

Schedule A (Form 990) 2022

Page 4

Part IV

Supporting Organizations

(Complete only if you checked a box on line 12 of Part I. If you checked box 12a, of Part I, complete Sections A and B. If you checked box 12b, of Part I, complete Sections A and C. If you checked box 12c, of Part I, complete Sections A, D, and E. If you checked box12d, of Part I, complete Sections A and D, and complete Part V.)

Section A. All Supporting Organizations

Yes

Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.

Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).

Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer lines 3b and 3c below.

Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.

Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.

Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked box 12a or 12b in Part I, answer lines 4b and 4c below.

Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations.

Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.

Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer lines 5b and 5c below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed; (ii) the reasons for each such action; (iii) the authority under the organization's organizing document authorizing such action; and (iv) how the action was accomplished (such as by amendment to the organizing document).

Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?

Substitutions only. Was the substitution the result of an event beyond the organization's control?

Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (i) its supported organizations, (ii) individuals that are part of the charitable class benefited by one or more of its supported organizations, or (iii) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.

Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in section 4958(c)(3)(C)), a family member of a substantial contributor, or a 35% controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990) .

Did the organization make a loan to a disqualified person (as defined in section 4958) not described on line 7? If “Yes,” complete Part I of Schedule L (Form 990).

Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons, as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.

Did one or more disqualified persons (as defined on line 9a) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.

Did a disqualified person (as defined on line 9a) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.

10a

Was the organization subject to the excess business holdings rules of section 4943 because of section 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer line 10b below.

10a

Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).

10b

Schedule A (Form 990) 2022

Page 5

Part IV

Supporting Organizations (continued)

Yes

Has the organization accepted a gift or contribution from any of the following persons?

A person who directly or indirectly controls, either alone or together with persons described on lines 11b and 11c below, the governing body of a supported organization?

11a

A family member of a person described on 11a above?

11b

A 35% controlled entity of a person described on line 11a or 11b above? If “Yes” to 11a, 11b, or 11c, provide detail in Part VI.

11c

Section B. Type I Supporting Organizations

Yes

Did the officers, directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.

Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.

Section C. Type II Supporting Organizations

Yes

Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).

Section D. All Type III Supporting Organizations

Yes

Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (i) a written notice describing the type and amount of support provided during the prior tax year, (ii) a copy of the Form 990 that was most recently filed as of the date of notification, and (iii) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?

Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).

By reason of the relationship described in line 2 above, did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.

Section E. Type III Functionally-Integrated Supporting Organizations

Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):

The organization satisfied the Activities Test. Complete line 2 below.

The organization is the parent of each of its supported organizations. Complete line 3 below.

The organization supported a governmental entity. Describe in Part VI how you supported a government entity (see instructions)

Activities Test. Answer lines 2a and 2b below.

Yes

Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.

Did the activities described on line 2a, above constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.

Parent of Supported Organizations. Answer lines 3a and 3b below.

Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations?If "Yes" or "No", provide details in Part VI.

Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI. the role played by the organization in this regard.

Schedule A (Form 990) 2022

Page 6

Part V

Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations

Check here if the organization satisfied the Integral Part Test as a qualifying trust on Nov. 20, 1970 (explain in Part VI). See instructions. All other Type III non-functionally integrated supporting organizations must complete Sections A through E.

	Section A - Adjusted Net Income		(A) Prior Year	(B) Current Year (optional)
1	Net short-term capital gain	1
2	Recoveries of prior-year distributions	2
3	Other gross income (see instructions)	3
4	Add lines 1 through 3	4
5	Depreciation and depletion	5
6	Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions)	6
7	Other expenses (see instructions)	7
8	Adjusted Net Income (subtract lines 5, 6 and 7 from line 4)	8

	Section B - Minimum Asset Amount		(A) Prior Year	(B) Current Year (optional)
1	Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year):	1
a	Average monthly value of securities	1a
b	Average monthly cash balances	1b
c	Fair market value of other non-exempt-use assets	1c
d	Total (add lines 1a, 1b, and 1c)	1d
e	Discount claimed for blockage or other factors (explain in detail in Part VI):
2	Acquisition indebtedness applicable to non-exempt use assets	2
3	Subtract line 2 from line 1d	3
4	Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions).	4
5	Net value of non-exempt-use assets (subtract line 4 from line 3)	5
6	Multiply line 5 by 0.035	6
7	Recoveries of prior-year distributions	7
8	Minimum Asset Amount (add line 7 to line 6)	8

	Section C - Distributable Amount		Current Year
1	Adjusted net income for prior year (from Section A, line 8, Column A)	1
2	Enter 85% of line 1	2
3	Minimum asset amount for prior year (from Section B, line 8, Column A)	3
4	Enter greater of line 2 or line 3	4
5	Income tax imposed in prior year	5
6	Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions)	6

Check here if the current year is the organization's first as a non-functionally-integrated Type III supporting organization (see instructions)

Schedule A (Form 990) 2022

Page 7

Part V

Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations(continued)

Section D - Distributions		Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes	1
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity	2
3 Administrative expenses paid to accomplish exempt purposes of supported organizations	3
4 Amounts paid to acquire exempt-use assets	4
5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI)	5
6 Other distributions (describe in Part VI). See instructions	6
7Total annual distributions. Add lines 1 through 6.	7
8 Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions	8
9 Distributable amount for 2022 from Section C, line 6	9
10 Line 8 amount divided by Line 9 amount	10

Section E - Distribution Allocations (see instructions)		(i) Excess Distributions	(ii) Underdistributions Pre-2022	(iii) Distributable Amount for 2022
1 Distributable amount for 2022 from Section C, line 6
2 Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI). See instructions.
3 Excess distributions carryover, if any, to 2022:
a From 2017.......
b From 2018.......
c From 2019.......
d From 2020.......
e From 2021.......
fTotal of lines 3a through e
g Applied to underdistributions of prior years
h Applied to 2022 distributable amount
i Carryover from 2017 not applied (see instructions)
j Remainder. Subtract lines 3g, 3h, and 3i from line 3f.
4Distributions for 2022 from Section D, line 7:
$
a Applied to underdistributions of prior years
b Applied to 2022 distributable amount
c Remainder. Subtract lines 4a and 4b from line 4.
5 Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions.
6 Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions.
7 Excess distributions carryover to 2023. Add lines 3j and 4c.
8 Breakdown of line 7:
a Excess from 2018.....
b Excess from 2019.....
c Excess from 2020.....
d Excess from 2021.....
e Excess from 2022.....

Schedule A (Form 990) (2022)

Schedule A (Form 990) 2022

Page 8

Part VI

Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).

Facts And Circumstances Test

Return Reference	Explanation

Schedule A (Form 990) 2022

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

- TIN:

Schedule B
(Form 990)

Department of the Treasury
Internal Revenue Service

Schedule of Contributors

Attach to Form 990, 990-EZ, or 990-PF.

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2022

Name of the organization

American Diabetes Association

Employer identification number

13-1623888

Organization type (check one):

Filers of:

Section:

Form 990 or 990-EZ

501(c)( ) (enter number) organization

4947(a)(1) nonexempt charitable trust not treated as a private foundation

527 political organization

Form 990-PF

501(c)(3) exempt private foundation

4947(a)(1) nonexempt charitable trust treated as a private foundation

501(c)(3) taxable private foundation

Check if your organization is covered by the General Rule or a Special Rule.
Note: Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.

General Rule

For an organization filing Form 990, 990-EZ, or 990-PF that received, during the year, contributions totaling $5,000 or more (in money or other property) from any one contributor. Complete Parts I and II. See instructions for determining a contributor's total contributions.

Special Rules

For an organization described in section 501(c)(3) filing Form 990 or 990-EZ that met the 33¹/3% support test of the regulations
under sections 509(a)(1) and 170(b)(1)(A)(vi), that checked Schedule A (Form 990 or 990-EZ), Part II, line 13, 16a, or 16b, and that received from any one contributor, during the year, total contributions of the greater of (1) $5,000 or (2) 2% of the amount on (i) Form 990, Part VIII, line 1h, or (ii) Form 990-EZ, line 1. Complete Parts I and II.

For an organization described in section 501(c)(7), (8), or (10) filing Form 990 or 990-EZ that received from any one contributor,
during the year, total contributions of more than $1,000 exclusively for religious, charitable, scientific, literary, or educational purposes, or for the prevention of cruelty to children or animals. Complete Parts I, II, and III.

For an organization described in section 501(c)(7), (8), or (10) filing Form 990 or 990-EZ that received from any one contributor,
during the year, contributions exclusively for religious, charitable, etc., purposes, but no such contributions totaled more than $1,000. If this box is checked, enter here the total contributions that were received during the year for an exclusively religious, charitable, etc., purpose. Don't complete any of the parts unless the General Rule applies to this organization because it received nonexclusively religious, charitable, etc., contributions totaling $5,000 or more during the year ......... Arrow Bullet

Caution: An organization that isn't covered by the General Rule and/or the Special Rules doesn't file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its Form 990-EZ
or on its Form 990PF, Part I, line 2, to certify that it doesn't meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).

For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.

Cat. No. 30613XSchedule B (Form 990) (2022)

Schedule B (Form 990) (2022) Page 2

Name of organization American Diabetes Association

Part I Contributors	Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
RESTRICTED	,	$ RESTRICTED	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
Schedule B (Form 990) (2022)

Schedule B (Form 990) (2022)

Page 3

Name of organization American Diabetes Association		Employer identification number 13-1623888

Part II	Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
Schedule B (Form 990) (2022)

Schedule B (Form 990) (2022)

Page 4


Name of organization American Diabetes Association			Employer identification number 13-1623888
Part III Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10) that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) $ Use duplicate copies of Part III if additional space is needed.

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

Schedule B (Form 990) (2022)

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

- TIN:

SCHEDULE C
(Form 990)

Department of the Treasury
Internal Revenue Service

Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527

SchCMd Bullet

Complete if the organization is described below. SchCMd Bullet

Attach to Form 990 or Form 990-EZ.
SchCMd Bullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2021

Open to Public
Inspection

If the organization answered "Yes" on Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet

Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet

Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet

Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" on Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet

Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet

Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" on Form 990, Part IV, Line 5 (Proxy Tax) (see separate instructions) or Form 990-EZ, Part V, line 35c (Proxy Tax) (see separate instructions), then
Round Bullet

Section 501(c)(4), (5), or (6) organizations: Complete Part III.

Name of the organization

American Diabetes Association

Employer identification number

13-1623888

Part I-A

Complete if the organization is exempt under section 501(c) or is a section 527 organization.

Provide a description of the organization’s direct and indirect political campaign activities in Part IV. See instructions for definition of “political campaign activities."

Political campaign activity expenditures. See instructions .................................................................... SchCMd Bullet

Volunteer hours for political campaign activities. See instructions ..................................................................

Part I-B

Complete if the organization is exempt under section 501(c)(3).

Enter the amount of any excise tax incurred by the organization under section 4955 ................................ SchCMd Bullet

Enter the amount of any excise tax incurred by organization managers under section 4955 ....................... SchCMd Bullet

If the organization incurred a section 4955 tax, did it file Form 4720 for this year? .........................................

Yes No

Was a correction made? ......................................................................................................................

Yes No

If "Yes," describe in Part IV.

Part I-C

Complete if the organization is exempt under section 501(c), except section 501(c)(3).

Enter the amount directly expended by the filing organization for section 527 exempt function activities ..... SchCMd Bullet

Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ............................................................................................................................ SchCMd Bullet

Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b........... SchCMd Bullet

Did the filing organization file Form 1120-POL for this year? ...................................................................

Yes No

Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.

(a) Name	(b) Address	(c) EIN	(d) Amount paid from filing organization's funds. If none, enter -0-.	(e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.
1
2
3
4
5
6

For Paperwork Reduction Act Notice, see the instructions for Form 990.

Cat. No. 50084S

Schedule C (Form 990) 2021

Page 2

Part II-A

Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).

A Check SchCMd Bullet

if the filing organization belongs to an affiliated group (and list in Part IV each affiliated group member's name, address, EIN, expenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet

if the filing organization checked box A and "limited control" provisions apply.

Limits on Lobbying Expenditures (The term "expenditures" means amounts paid or incurred.)		(b) Affiliated group totals
1a	Total lobbying expenditures to influence public opinion (grass roots lobbying) ......................
b	Total lobbying expenditures to influence a legislative body (direct lobbying) ........................
c	Total lobbying expenditures (add lines 1a and 1b) ............................................................
d	Other exempt purpose expenditures ...............................................................................
e	Total exempt purpose expenditures (add lines 1c and 1d) ..................................................
f	Lobbying nontaxable amount. Enter the amount from the following table in both columns.
	If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
	Not over $500,00020% of the amount on line 1e.
	Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
	Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
	Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
	Over $17,000,000$1,000,000.

g	Grassroots nontaxable amount (enter 25% of line 1f) .................................................
h	Subtract line 1g from line 1a. If zero or less, enter -0-. ................................................
i	Subtract line 1f from line 1c. If zero or less, enter -0-. ................................................
j	If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting section 4911 tax for this year? ...................................................................................................................	Yes No

4-Year Averaging Period Under Section 501(h) (Some organizations that made a section 501(h) election do not have to complete all of the five columns below. See the separate instructions for lines 2a through 2f.)
Lobbying Expenditures During 4-Year Averaging Period
	Calendar year (or fiscal year beginning in)	(a) 2018	(b) 2019	(c) 2020	(d) 2021	(e) Total

2a	Lobbying nontaxable amount

b	Lobbying ceiling amount (150% of line 2a, column(e))

c	Total lobbying expenditures

d	Grassroots nontaxable amount

e	Grassroots ceiling amount (150% of line 2d, column (e))

f	Grassroots lobbying expenditures

Schedule C (Form 990) 2021

Page 3

Part II-B

Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).

For each "Yes" response on lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.

(a)

Yes|No

(b)

Amount

During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:

Volunteers? ...........................................................................................................

Yes

Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ........

Yes

Media advertisements? ...................................................................................................

Yes

150,000

Mailings to members, legislators, or the public? .............................................................................

Yes

48,683

Publications, or published or broadcast statements? ...........................................................

Grants to other organizations for lobbying purposes? ..........................................................

Direct contact with legislators, their staffs, government officials, or a legislative body? .......................

Yes

390,958

Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ..................

Yes

23,660

Other activities? ...................................................................................................................

Total. Add lines 1c through 1i ....................................................................................................

613,301

Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....

If "Yes," enter the amount of any tax incurred under section 4912 ...........................................

If "Yes," enter the amount of any tax incurred by organization managers under section 4912 ...................

If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? ........................

Part III-A

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).

Yes

Were substantially all (90% or more) dues received nondeductible by members? ...............................................

Did the organization make only in-house lobbying expenditures of $2,000 or less? ............................................

Did the organization agree to carry over lobbying and political expenditures from the prior year? .................................

Part III-B

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."

Dues, assessments and similar amounts from members ......................................................................

Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political expenses for which the section 527(f) tax was paid).

Current year .............................................................................................................................

Carryover from last year ............................................................................................................

Total ...........................................................................................................................................

Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .

If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ......................................................................................................................

Taxable amount of lobbying and political expenditures. See Instructions .........................................

Part IV

Supplemental Information

Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, lines 1 and 2 (see instructions), and Part ll-B, line 1. Also, complete this part for any additional information.

Return Reference	Explanation
II-B	The American Diabetes Associations advocacy efforts and achievements are at the core of creating effective and lasting change for people living with and at risk for diabetes. Raising our voices from Capitol Hill to state legislatures across the country, our dedicated Diabetes Advocates continue to drive momentum in our ongoing fight to stop diabetes. Our advocacy work gives people with diabetes, their families and health care professionals the power to influence public policy issues that affect people with diabetes at the local, state and national levels. Our advocacy priorities include Increasing federal and state funding for diabetes prevention, treatment, and research. Improving access to adequate and affordable health care. Ending discrimination people with diabetes face at school, work and elsewhere in their lives. Achieving health equity. Addressing health disparities people with diabetes face during the COVID19 pandemic. In 2022, the ADA achieved Increased funding for the National Institute of Diabetes and Digestive and Kidney Diseases from 2.204 billion in FY2022 to 2.300 billion in FY2023, increased funding for the Centers for Disease Control and Prevention Division of Diabetes from 153.1 million in FY2022 to 155.1 million in FY2023 and increased funding for the National Diabetes Prevention Program from 34.3 million in FY2022 to 37.3 million in FY2023, and funding for the Advanced Research Projects Agency for Health 1.500 billion 50 increase over FY2022.
II-B	Participated in hundreds of meetings, briefings events and other actions in support of our advocacy priorities which led to 130 legislative and regulatory wins at the state and federal levels. Hosted a Roundtable discussion on promoting clinical trial diversity for people with diabetes. The roundtable brought together key stakeholders in diabetes advocacy, industry, and government who pinpointed best practices, reviewed current clinical diversity recommendations and policies, and developed consensus recommendations aimed at advancing best practices and policy changes leading to increased diversity in diabetes-focused clinical trials. Supported the passage of the first ever, national co pay cap for insulin in the Inflation Reduction Act. Educated and inspired action among our 500,000 advocates about state and legal advocacy through calls to action and updates throughout the year. Improved access to continuous glucose monitors for Medicare beneficiaries and Medicaid beneficiaries in more than ten states. Increased access to nutritious foods through increased funding for SNAP benefits, healthy food financing, school based meal assistance programs, and other state level health equity legislation that impacts communities across the country. Published guidance and resources for parents and school personnel on diabetes management in the school setting and published a new tool, the Diabetes Medical Management Plan for use by schools and pediatric diabetes health care providers nationwide. The new tool allowed for more standardized, efficient completion of student diabetes care orders. Launched the Amputation Prevention Alliance, a group of stakeholders united against the rising rates of diabetes related amputations. The APA published policy priorities, convened a clinical advisory working group, and hosted several events aimed at raising awareness and support for necessary policy changes aimed at reducing the rate of diabetes related amputations.

Return Reference

Explanation

II-B

The American Diabetes Associations advocacy efforts and achievements are at the core of creating effective and lasting change for people living with and at risk for diabetes. Raising our voices from Capitol Hill to state legislatures across the country, our dedicated Diabetes Advocates continue to drive momentum in our ongoing fight to stop diabetes. Our advocacy work gives people with diabetes, their families and health care professionals the power to influence public policy issues that affect people with diabetes at the local, state and national levels. Our advocacy priorities include Increasing federal and state funding for diabetes prevention, treatment, and research. Improving access to adequate and affordable health care. Ending discrimination people with diabetes face at school, work and elsewhere in their lives. Achieving health equity. Addressing health disparities people with diabetes face during the COVID19 pandemic. In 2022, the ADA achieved Increased funding for the National Institute of Diabetes and Digestive and Kidney Diseases from 2.204 billion in FY2022 to 2.300 billion in FY2023, increased funding for the Centers for Disease Control and Prevention Division of Diabetes from 153.1 million in FY2022 to 155.1 million in FY2023 and increased funding for the National Diabetes Prevention Program from 34.3 million in FY2022 to 37.3 million in FY2023, and funding for the Advanced Research Projects Agency for Health 1.500 billion 50 increase over FY2022.

II-B

Participated in hundreds of meetings, briefings events and other actions in support of our advocacy priorities which led to 130 legislative and regulatory wins at the state and federal levels. Hosted a Roundtable discussion on promoting clinical trial diversity for people with diabetes. The roundtable brought together key stakeholders in diabetes advocacy, industry, and government who pinpointed best practices, reviewed current clinical diversity recommendations and policies, and developed consensus recommendations aimed at advancing best practices and policy changes leading to increased diversity in diabetes-focused clinical trials. Supported the passage of the first ever, national co pay cap for insulin in the Inflation Reduction Act. Educated and inspired action among our 500,000 advocates about state and legal advocacy through calls to action and updates throughout the year. Improved access to continuous glucose monitors for Medicare beneficiaries and Medicaid beneficiaries in more than ten states. Increased access to nutritious foods through increased funding for SNAP benefits, healthy food financing, school based meal assistance programs, and other state level health equity legislation that impacts communities across the country. Published guidance and resources for parents and school personnel on diabetes management in the school setting and published a new tool, the Diabetes Medical Management Plan for use by schools and pediatric diabetes health care providers nationwide. The new tool allowed for more standardized, efficient completion of student diabetes care orders. Launched the Amputation Prevention Alliance, a group of stakeholders united against the rising rates of diabetes related amputations. The APA published policy priorities, convened a clinical advisory working group, and hosted several events aimed at raising awareness and support for necessary policy changes aimed at reducing the rate of diabetes related amputations.

Schedule C (Form 990) 2021

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

- TIN:

SCHEDULE D
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Financial Statements

Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet

Attach to Form 990.
SchDMd Bullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2021

Open to Public Inspection

Name of the organization

American Diabetes Association

Employer identification number

13-1623888

Part I

Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.

		(a) Donor advised funds
1	Total number at end of year .........	1
2	Aggregate value of contributions to (during year)
3	Aggregate value of grants from (during year)
4	Aggregate value at end of year ........	712,516

Did the organization inform all donors and donor advisors in writing that the assets held in donor advised funds are the organization’s property, subject to the organization’s exclusive legal control? ............

Yes No

Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................

Yes No

Part II

Conservation Easements.
Complete if the organization answered "Yes" on Form 990, Part IV, line 7.

Purpose(s) of conservation easements held by the organization (check all that apply).

Preservation of land for public use (e.g., recreation or education) Preservation of an historically important land area

Protection of natural habitat Preservation of a certified historic structure

Preservation of open space

Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.


a	Total number of conservation easements ......................	2a
b	Total acreage restricted by conservation easements ....................	2b
c	Number of conservation easements on a certified historic structure included in (a) .....	2c
d	Number of conservation easements included in (c) acquired after 7/25/06, and not on a historic structure listed in the National Register ...	2d

Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year SchDMd Bullet

Number of states where property subject to conservation easement is located SchDMd Bullet

Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............

Yes No

Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet

Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet

Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................

Yes No

In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.

If the organization elected, as permitted under FASB ASC 958, not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.

If the organization elected, as permitted under FASB ASC 958, to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:

(i)

Revenue included on Form 990, Part VIII, line 1 ......................... SchDMd Bullet

(ii)

Assets included in Form 990, Part X ............................... SchDMd Bullet

If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under FASB ASC 958 relating to these items:

Revenue included on Form 990, Part VIII, line 1 .......................... SchDMd Bullet

Assets included in Form 990, Part X ............................... SchDMd Bullet

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 52283D

Schedule D (Form 990) 2021

Page 2

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)

Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):

Public exhibition

Loan or exchange programs

Scholarly research

Other

Preservation for future generations

Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.

During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...

Yes No

Part IV

Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.

Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................

Yes No


b	If "Yes," explain the arrangement in Part XIII and complete the following table:		Amount
c	Beginning balance .............................	1c
d	Additions during the year ............................	1d
e	Distributions during the year ..........................	1e
f	Ending balance ................................	1f

Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability? ...

Yes No

If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ....

Part V

Endowment Funds.
Complete if the organization answered "Yes" on Form 990, Part IV, line 10.

		(a) Current year	(b) Prior year	(c) Two years back	(d) Three years back	(e) Four years back

1a	Beginning of year balance ....	22,804,536	23,164,825	23,451,734	22,635,671	22,899,249
b	Contributions ...		-5,530	371	80,442	4,547
c	Net investment earnings, gains, and losses	386,389	2,154,099	2,318,586	2,949,834	1,449,845
d	Grants or scholarships ...	1,754,951	2,508,858	2,605,866	2,214,213	1,717,970
e	Other expenditures for facilities and programs ...
f	Administrative expenses ....
g	End of year balance ......	21,435,974	22,804,536	23,164,825	23,451,734	22,635,671

Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:

Board designated or quasi-endowment SchDMd Bullet

Permanent endowment SchDMd Bullet

19.000 %

Term endowment SchDMd Bullet

81.000 %

The percentages on lines 2a, 2b, and 2c should equal 100%.

Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes

(i) Unrelated organizations .................

3a(i)

Yes

(ii) Related organizations .................

3a(ii)

Yes

If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........

Yes

Describe in Part XIII the intended uses of the organization's endowment funds.

Part VI

Land, Buildings, and Equipment.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.

Description of property		(a) Cost or other basis (investment)	(b) Cost or other basis (other)	(c) Accumulated depreciation	(d) Book value

1a	Land .....	4,500		4,500
b	Buildings ....
c	Leasehold improvements	5,826,966	3,538,042	2,288,924
d	Equipment ....	8,048,428	7,252,888	795,540
e	Other .....	13,367,126	12,216,194	1,150,932
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..				4,239,896

Schedule D (Form 990) 2021

Page 3

Part VII

Investments - Other Securities.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.

(a) Description of security or category (including name of security)	(b) Book value	(c) Method of valuation: Cost or end-of-year market value
(1) Financial derivatives.........
(2) Closely-held equity interests........
(3) Other (A) Financial derivatives and other financial products
(B) Closely-held equity interests
(C) Perpetual Trusts	11,104,921	F
(C)
(D)
(E)
(F)
(G)
(H)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)	11,104,921

Part VIII

Investments - Program Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.

(a) Description of investment	(b) Book value	(c) Method of valuation: Cost or end-of-year market value

(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)

Part IX

Other Assets.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.

(a) Description				(b) Book value
(1)Due From Property Title Holding Corporation				6,856,343
(2)Investment in Net Assets of American Diabetes Association Property Title Holding Corporation				12,817,875
(3)Right-of-Use Assets - Operating Leases				15,944,242
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........				35,618,460

Part X

Other Liabilities.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.

1.(a) Description of liability	(b) Book value
(1) Federal income taxes
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)	27,206,190
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII

Schedule D (Form 990) 2021

Page 4

Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1	Total revenue, gains, and other support per audited financial statements .......		1
2	Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a	Net unrealized gains (losses) on investments ....	2a
b	Donated services and use of facilities .........	2b
c	Recoveries of prior year grants ...........	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d .....................		2e
3	Subtract line 2e from line 1..................		3
4	Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b .	4a
b	Other (Describe in Part XIII.) ...........	4b
c	Add lines 4a and 4b....................		4c
5	Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ......		5

Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1	Total expenses and losses per audited financial statements ...........		1
2	Amounts included on line 1 but not on Form 990, Part IX, line 25:
a	Donated services and use of facilities .........	2a
b	Prior year adjustments ............	2b
c	Other losses ................	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d....................		2e
3	Subtract line 2e from line 1...................		3
4	Amounts included on Form 990, Part IX, line 25, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b ..	4a
b	Other (Describe in Part XIII.) ............	4b
c	Add lines 4a and 4b.....................		4c
5	Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ......		5

Part XIII

Supplemental Information

Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b; Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.

Return Reference	Explanation
V 4	The following was disclosed in the consolidated financial statements related to the intended use of the ADA endowment funds The ADA has adopted an investment policy for endowment assets that provides continued financial stability for the ADA and a revenue stream for spending on the ADA mission.
V 4	To fulfill this mission, the American Diabetes Association funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals, and the public.
X 2	The following was disclosed related to uncertain tax positions in the audited financial statements The American Diabetes Association is generally exempt from income taxes under Section 501c3 of the Internal Revenue Code the Code and charitable contributions to these organizations qualify for tax deductions as described in the Code. PTHC is generally exempt from income taxes under Section 501c2 of the Code. These entities are subject to taxation on any net unrelated business income and have been classified as organizations that are not private foundations under Section 509a of the Code. ADA recognizes the effect of income tax positions only if those positions more likely than not would not be sustained upon examination by the Internal Revenue Service. ADA has analyzed the tax positions taken and has concluded that as of December 31, 2022, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liablility or asset or disclosure in the consolidated financial statements. ADA is open to examination by taxing authorities for the years ended December 31, 2019 and forward.

Schedule D (Form 990) 2021

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

- TIN:

SCHEDULE G (Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Information Regarding
Fundraising or Gaming Activities

Complete if the organization answered "Yes" on Form 990, Part IV, lines 17, 18, or 19, or if the organization entered more than $15,000 on Form 990-EZ, line 6a. right arrow

Attach to Form 990 or Form 990-EZ.
right arrow

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2022

Open to Public Inspection

Name of the organization
American Diabetes Association

Employer identification number

13-1623888

Part I

Fundraising Activities.Complete if the organization answered "Yes" on Form 990, Part IV, line 17.

Form 990-EZ filers are not required to complete this part.

Indicate whether the organization raised funds through any of the following activities. Check all that apply.

a	Mail solicitations	e	Solicitation of non-government grants
b	Internet and email solicitations	f	Solicitation of government grants
c	Phone solicitations	g	Special fundraising events
d	In-person solicitations

Did the organization have a written or oral agreement with any individual (including officers, directors, trustees

or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?

YesNo

If "Yes," list the 10 highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization.

(i) Name and address of individual or entity (fundraiser)		(ii) Activity	(iii) Did fundraiser have custody or control of contributions?		(iv) Gross receipts from activity	(v) Amount paid to (or retained by) fundraiser listed in col. (i)	(vi) Amount paid to (or retained by) organization
			Yes	No
	Chapman Cubine Allen & Hussey Inc 2000 N 15th Street Arlington, VA22201	See Part IV		No	9,167,860	566,400	8,601,460
	Charitable Adult Rides & Services Inc 4669 Murphy Canyon Road Suite 200 San Diego, CA92123	See Part IV	Yes		657,200	193,871	463,329
	Forward PMX One World Trade Center 63rd Floor New York, NY10007	See Part IV		No	1,475,612	325,742	1,149,870
	GoodUnited Inc 796 Meeting Street Charleston, SC29403	See Part IV		No	1,262,829	89,743	1,173,086






Total . . . . . . . . . . . . . . . . . . . .					12,563,501	1,175,756	11,387,745

List all states in which the organization is registered or licensed to solicit contributions or has been notified it is exempt from registration or licensing.

AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 50083H

Schedule G (Form 990) 2022

Page 2

Part II

Fundraising Events. Complete if the organization answered "Yes" on Form 990, Part IV, line 18, or reported more than $15,000 of fundraising event contributions and gross income on Form 990-EZ, lines 1 and 6b. List events with gross receipts greater than $5,000.

		(a) Event #1 Step Out (event type)	(b) Event #2 Tour de Cure (event type)	(c) Other events 1 (total number)	(d) Total events (add col. (a) through col. (c))
1	Gross receipts . . . . .	1,662,377	5,789,817	2,844,432	10,296,626
2	Less: Contributions . . . .	1,400,457	4,938,108	2,442,399	8,780,964
3	Gross income (line 1 minus line 2) . . . . . .	261,920	851,709	402,033	1,515,662

4	Cash prizes . . . . .
5	Noncash prizes . . . .	32,323	207,056	21,034	260,413
6	Rent/facility costs . . . .	140,034	296,749	249,364	686,147
7	Food and beverages . . .
8	Entertainment . . . .
9	Other direct expenses . . .	89,563	347,904	131,635	569,102
10	Direct expense summary. Add lines 4 through 9 in column (d) . . . . . . . . . .				1,515,662
11	Net income summary. Subtract line 10 from line 3, column (d). . . . . . . . . .

Part III

Gaming. Complete if the organization answered "Yes" on Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.

		(a) Bingo	(b) Pull tabs/Instant bingo/progressive bingo	(c) Other gaming	(d) Total gaming (add col.(a) through col.(c))
1	Gross revenue . . . . .

2	Cash prizes . . . . .
3	Noncash prizes . . . .
4	Rent/facility costs . . . .
5	Other direct expenses . . .

Volunteer labor . . . .

	Yes %
	No

	Yes %
	No

	Yes %
	No

Direct expense summary. Add lines 2 through 5 in column (d) . . . . . . . . . . right arrow

Net gaming income summary. Subtract line 7 from line 1, column (d). . . . . . . . . right arrow

Enter the state(s) in which the organization conducts gaming activities:

Is the organization licensed to conduct gaming activities in each of these states? . . . . . . . .

YesNo

If "No," explain:

10a

Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? . . .

YesNo

If "Yes," explain:

Schedule G (Form 990) 2022

Page 3

Does the organization conduct gaming activities with nonmembers? . . . . . . . . . . .

YesNo

Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity

formed to administer charitable gaming? . . . . . . . . . . . . . . . . .

YesNo

Indicate the percentage of gaming activity conducted in:

The organization's facility . . . . . . . . . . . . . . . . . .

13a

An outside facility . . . . . . . . . . . . . . . . . . . .

13b

Enter the name and address of the person who prepares the organization's gaming/special events books and records:

Name

Address

15a

Does the organization have a contract with a third party from whom the organization receives gaming

revenue? . . . . . . . . . . . . . . . . . . . . . . . .

YesNo

If "Yes," enter the amount of gaming revenue received by the organization right arrow

$ and the

amount of gaming revenue retained by the third party right arrow

$ .

If "Yes," enter name and address of the third party:

Name

Address

Gaming manager information:

Name

Gaming manager compensation right arrow

Description of services provided right arrow

Director/officer Employee Independent contractor

Mandatory distributions:

Is the organization required under state law to make charitable distributions from the gaming proceeds to

retain the state gaming license? . . . . . . . . . . . . . . . . . . .

YesNo

Enter the amount of distributions required under state law distributed to other exempt organizations or spent

in the organization's own exempt activities during the tax year right arrow

Part IV

Supplemental Information. Provide the explanations required by Part I, line 2b, columns (iii) and (v); and Part III, lines 9, 9b, 10b, 15b, 15c, 16, and 17b, as applicable. Also provide any additional information. See instructions.

Return Reference	Explanation
Part I Line 2b1	Chapman Cubine Allen Hussey, Inc. activities are strategic services including account and project management, data processing analysis and reporting, meeting, and/or project services requested by ADA.
Part I Line 2b2	Charitable Adult Rides Services, Inc. activities are advertising, acquisition and disposal of donated vehicles solicited by American Diabetes Association.
Part I Line 2b2	Upon sale of the donated vehicle, the funds are deposited into the Charitable Adult Rides Services, Inc. bank account. The net proceeds from the donated car are then sent by Charitable Adult Rides Services, Inc. to the American Diabetes Association bank account.
Part I Line 2b3	Forward PMX activities are to provide program strategy and media management through various media channels to drive fundraising revenue for the ADAs direct response fundraising program.
Part I Line 2b4	GoodUnited, Inc. activities are to help ADA find and engage with supporters on social media in the channel where they spend time.

Schedule G (Form 990) 2022

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

- TIN:

Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule I
(Form 990)

Department of the Treasury
Internal Revenue Service

Grants and Other Assistance to Organizations,
Governments and Individuals in the United States

Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet

Attach to Form 990.
lBullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2022

Open to Public
Inspection

Name of the organization
American Diabetes Association

Employer identification number
13-1623888

Part I

General Information on Grants and Assistance

Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................

Yes No

Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.

Part II

Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient

that received more than $5,000. Part II can be duplicated if additional space is needed.

(a) Name and address of organization or government	(b) EIN	(c) IRC section (if applicable)	(d) Amount of cash grant	(h) Purpose of grant or assistance
(1) American Academy of Physician Associates 2318 Mill Road Suite 1300 Alexandria,VA22314	23-7067770	501 c6	20,000	Education and Development
(2) American Association of Nurse Practitioners 5901 Vega Avenue Suite 200 Austin,TX78735	22-2547543	501 c6	30,000	Education and Development
(3) American Pharmacists Association Foundation 2215 Constitution Avenue NW Washington,DC20037	52-6039142	501 c3	50,000	Education and Development
(4) American Society of Health-System Pharmacists 4500 East-West Highway Suite 900 Bethesda,MD20814	52-0807628	501 c3	30,000	Education and Development
(5) Association of Diabetes Care & Education Specialists 125 South Wacker Drive Suite 600 Chicago,IL60606	51-0161670	501 c6	20,000	Education and Development
(6) Diabetes Education and Camping Association 12557 New Brittany Boulevard Fort Myers,FL33907	63-1187548	501 c3	5,000	Education and Development
(7) Garland Independent School District 501 South Jupiter Garland,TX75042	75-6001650		42,000	Education and Development
(8) Health Resources In Action Inc 2 Boylston Street 4th Floor Boston,MA02116	04-2229839	501 c3	100,000	Education and Development
(9) Ochsner Clinic Foundation 1514 Jefferson Highway New Orleans,LA70121	72-0502505	501 c3	5,500	Education and Development
(10) Profit Financial Group 314 Comiskey Park Circle Summerville,SC29485	83-2014629		12,700	Education and Development
(11) T-1 Today Inc 8216 Princeton-Glendale Road Suite West Chester,OH45069	46-3704802	501 c3	80,000	Education and Development
(12) Taking Control of Your Diabetes 990 Highland Drive Suite 312 Solana Beach,CA92075	33-0794608	501 c3	37,000	Education and Development
(13) Temple Center for Population Health LLC 3509 North Broad Street Philadelphia,PA19140	23-2825881	501 c3	45,000	Education and Development
(14) Top Box Foods 222 West Merchandise Mart Plaza Chicago,IL60654	45-3930886	501 c3	14,000	Education and Development
(15) United Clergy Task Force Inc 209 Plains Drive Burlington,NC27217	47-5459058	501 c3	6,000	Education and Development
(16) Urban Community Health and Wellness 5924 Victoria Park Way North Chesterfield,VA23234	87-1306059	170b1	6,500	Education and Development
(17) University of Connecticut School of Nursing 231 Glenbrook Road Storrs,CT06269	06-0772160	115	200,000	Innovative Clinical or Translational Science New Health Disparities
(18) University of Washington 1201 Larimer Street Seattle,WA99164	91-6001108	501c3	200,000	Innovative Clinical or Translational Science New Health Disparities
(19) Indiana University PO Box 500 Bloomington,IN47402	35-6018940	501c3	200,000	Innovative Clinical or Translational Science New Health Disparities
(20) University of Colorado 1800 Grant Street Suite 600 Denver,CO80203	84-6000555	501c3	200,000	Innovative Clinical/Translational Science Nutrition
(21) New York University School of Medicine 550 First Avenue New York,NY10016	13-5562308	501c3	200,000	Innovative Clinical/Translational Science Nutrition
(22) University of Utah 201 South Presidents Circle Rm 406 Salt Lake City,UT84112	87-6000525	501c3	200,000	Innovative Clinical/Translational Science Nutrition
(23) University of Colorado 1800 Grant Street Suite 600 Denver,CO80203	84-6000555	501c3	200,000	Innovative Clinical/Translational Science Precision Medicine
(24) University of Virginia 1001 North Emmet Street Charlottesville,VA22904	54-6001796	501c3	200,000	Innovative Clinical/Translational Science Precision Medicine
(25) Partners Healthcare System Inc 399 Revolution Dr Ste 645 Somerville,MA021451465	04-2103561	501c3	200,000	Innovative Clinical/Translational Science Precision Medicine
(26) University of Utah 201 South Presidents Circle Rm 406 Salt Lake City,UT84112	87-6000525	501c3	200,000	Innovative Clinical/Translational Science Precision Medicine
(27) University of Colorado Anschutz Medical Campus 13001 East 17th Place Aurora,CO80045	84-6000555	501c3	200,000	Innovative Clinical or Translational Science Nutrition
(28) University of Utah 201 South Presidents Circle Rm 406 Salt Lake City,UT84112	87-6000525	501c3	200,000	Innovative Clinical or Translational Science Nutrition
(29) University of California San Francisco 3333 California Street Ste 315 San Francisco,CA910103012	95-3432210	501c3	200,000	Innovative Clinical or Translational Science Nutrition
(30) Stanford University 3145 Porter Drive Palo Alto,CA93407	20-4927897	501c3	200,000	Innovative Clinical or Translational Science Nutrition
(31) Clemson University 391 College Avenue Suite 301 Clemson,SC29634	57-6000254	501c3	200,000	Innovative Clinical or Translational Science Nutrition
(32) University of North Carolina at Chapel Hill 104 Airport Dr Ste 2200 CD1350 Chapel Hill,NC27157	22-3849199	501c3	200,000	Innovative Clinical or Translational Science Nutrition
(33) Childrens Hospital Los Angeles 4650 Sunset Boulevard Los Angeles,CA90027	95-1690977	501c3	200,000	Innovative Clinical or Translational Science Nutrition
(34) Michigan State University 426 Auditorium Road East Lansing,MI48824	38-6005984	501c3	200,000	Innovative Clinical or Translational Science Nutrition
(35) Eastern Virginia Medical School PO Box 1980 Norfolk,VA23501	54-6055378	501c3	199,999	Innovative Clinical or Translational Science Nutrition
(36) University of Michigan 3003 S State St Rm 1054 Ann Arbor,MI48202	38-6028429	501c3	199,999	Innovative Clinical or Translational Science Nutrition
(37) President and Fellows of Harvard College 1033 Massachusetts Ave Third Floor Cambridge,MA01655	04-3167352	115	199,999	Innovative Clinical or Translational Science Nutrition
(38) Denver Health and Hospital Authority 655 Broadway Denver,CO80203	84-1343242	501c3	199,998	Innovative Clinical/Translational Science Nutrition
(39) The Regents of the University of Michigan 3003 South State Street Ann Arbor,MI48109	38-6028429	501c3	199,998	Innovative Clinical or Translational Science Health Disparities
(40) Broad Institute Inc 415 Main Street Cambridge,MA02142	26-3428781	501c3	199,989	Innovative Clinical or Translational Science Health Disparities
(41) George Washington University 1922 F Street NW 4th Floor Washington,DC20052	53-0196584	501c3	199,984	Innovative Clinical or Translational Science New Health Disparities
(42) Regents of the University of California 1111 Franklin Street 10th Floor Oakland,CA92093	95-6006144	501c3	199,973	Innovative Clinical or Translational Science Health Disparities
(43) Children's Hospital Corporation 301 Longwood Ave Boston,MA01655	04-3167352	115	199,973	Innovative Clinical or Translational Science Health Disparities
(44) Gretchen Swanson Center for Nutrition 505 Durham Research Plaza Omaha,NE68105	23-7175802	501c3	199,926	Innovative Clinical/Translational Science Nutrition
(45) University of North Carolina at Chapel Hill 104 Airport Dr Ste 2200 CD1350 Chapel Hill,NC27157	22-3849199	501c3	199,877	Innovative Clinical or Translational Science New Health Disparities
(46) Kaiser Permanente Northern California One Kaiser Plaza Oakland,CA94612	94-1340523	501c3	199,818	Innovative Clinical or Translational Science New Health Disparities
(47) Northwestern University Medical School 420 East Superior Street Chicago,IL60611	36-2167817	501c3	199,801	Innovative Clinical or Translational Science Health Disparities
(48) University of Tennessee 1331 Circle Park Drive Knoxville,TN37916	62-6001636	170c1	199,783	Innovative Clinical or Translational Science Health Disparities
(49) University of Kentucky Research Foundation 301 Peterson Service Building Lexington,KY40506	61-6033693	501c3	199,642	Innovative Clinical or Translational Science Health Disparities
(50) Connecticut Children's Medical Center Foundation 282 Washington Street Hartford,CT06106	22-2619869	501c3	199,628	Innovative Clinical or Translational Science Health Disparities
(51) University of Texas Southwestern Medical Center at Dallas PO Box 841753 Dallas,TX77840	74-2245072	501c3	199,513	Innovative Clinical or Translational Science Health Disparities
(52) Ohio State University 1960 Kenny Road Columbus,OH45701	31-6402269	501c3	199,189	Innovative Clinical or Translational Science Health Disparities
(53) University of Colorado Anschutz Medical Campus 13001 East 17th Place Aurora,CO80045	84-6000555	501c3	199,143	Innovative Clinical or Translational Science Health Disparities
(54) Colorado School of Public Health 13001 East 17th Place Aurora,CO80045	84-6000555	501c3	198,496	Innovative Clinical/Translational Science Precision Medicine
(55) Wake Forest University Health Sciences Medical Center Boulevard WinstonSalem,NC27157	22-3849199	501c3	198,362	Innovative Clinical or Translational Science Nutrition
(56) University of Utah 201 South Presidents Circle Rm 406 Salt Lake City,UT84112	87-6000525	501c3	197,495	Innovative Clinical or Translational Science Nutrition
(57) Partners Healthcare System Inc 399 Revolution Dr Ste 645 Somerville,MA021451465	04-2103561	501c3	196,859	Innovative Clinical or Translational Science Nutrition
(58) University of Chicago 5801 South Ellis Avenue Chicago,IL60637	36-2177139	501c3	196,259	Innovative Clinical/Translational Science Precision Medicine
(59) The Board of Regents of the University of Wisconsin System 21 N Park Street Suite 6401 Madison,WI53226	39-0806261	501c3	194,500	Innovative Clinical or Translational Science New Health Disparities
(60) Ann and Robert H Lurie Children's Hospital of Chicago 225 E Chicago Ave Chicago,IL60611	36-2170833	501c3	177,976	Innovative Clinical or Translational Science New Health Disparities
(61) Georgia Institute of Technology 500 Tech Parkway NW Atlanta,GA30332	58-6002023	501c3	174,996	Innovative Clinical or Translational Science Health Disparities
(62) University of North Carolina at Chapel Hill 104 Airport Dr Ste 2200 CD1350 Chapel Hill,NC27157	22-3849199	501c3	164,614	Junior Faculty Development
(63) University of Michigan 3003 S State St Rm 1054 Ann Arbor,MI48202	38-6028429	501c3	138,000	Junior Faculty
(64) University of Iowa 4 Jessup Hall Room B5 Iowa City,IA52242	42-6004813	115	138,000	Junior Faculty
(65) Indiana University PO Box 500 Bloomington,IN47402	35-6018940	501c3	138,000	Junior Faculty
(66) Florida State University Research Foundation Inc 2000 Levy Avenue Tallahassee,FL32310	59-3211153	501c3	138,000	Junior Faculty Development Precision Medicine
(67) City of Hope Beckman Research Institute 1500 East Duarte Road Duarte,CA94305	94-1156365	501c3	138,000	Junior Faculty Development
(68) Georgia State University Research Foundation Inc 33 Gilmer Street SE Atlanta,GA30303	58-1845423	501c3	138,000	Junior Faculty Development
(69) Beckman Research Institute of City of Hope 1500 East Duarte Road Duarte,CA94305	94-1156365	501c3	138,000	Junior Faculty Development
(70) University of Miami 1252 Memorial Drive Coral Gables,FL33146	59-0624458	501c3	137,999	Junior Faculty Development Precision Medicine
(71) Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee,WI53226	39-0806261	501c3	137,998	Junior Faculty Development Precision Medicine
(72) HealthPartners Institute 8170 33rd Avenue South Minneapolis,MN55440	41-1670163	501c3	137,997	Junior Faculty Nutrition
(73) University of Cincinnati 51 Goodman Drive Cincinnati,OH45221	31-6000989	501c3	137,995	Junior Faculty Development Precision Medicine
(74) University of Texas at Austin 601 Colorado Street Austin,TX78701	74-6000203	170c1	137,995	Junior Faculty Development Precision Medicine
(75) University of Arizona 2700 N Central Ave Suite 850 Phoenix,AZ85004	74-2652689	170c1	137,991	Junior Faculty Development Precision Medicine
(76) University of Kansas Medical Center Research Institute Inc 3901 Rainbow Boulevard Kansas City,KS66160	48-1108830	501c3	137,989	Junior Faculty Nutrition
(77) University of Florida 903 West University Avenue Gainesville,FL32601	59-6002052	170c1	137,985	Junior Faculty Precision Medicine
(78) Case Western Reserve University 10900 Euclid Avenue Cleveland,OH45701	31-6402269	501c3	137,974	Innovative Clinical or Translational Science New Health Disparities
(79) Yale University 155 Whitney Avenue Room 230 PO Box New Haven,CT06510	06-0646973	501c3	137,874	Junior Faculty Nutrition
(80) Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee,WI53226	39-0806261	501c3	137,836	Junior Faculty Development
(81) University of Colorado 1800 Grant Street Suite 600 Denver,CO80203	84-6000555	501c3	137,736	Junior Faculty Development Precision Medicine
(82) University of Wyoming 1000 East University Avenue Laramie,WY82071	83-6000331	501c3	137,696	Junior Faculty Development Precision Medicine
(83) University of Massachusetts Amherst-Pioneer Valley Life Science Institute 3601 Main Street Springfield,MA01001	57-1183126	501c3	137,512	Junior Faculty Development Precision Medicine
(84) Partners Healthcare System Inc 399 Revolution Dr Ste 645 Somerville,MA021451465	04-2103561	501c3	134,059	Junior Faculty
(85) University of Colorado Anschutz Medical Campus 13001 East 17th Place Aurora,CO80045	84-6000555	501c3	131,766	Innovative Clinical or Translational Science Nutrition
(86) Colorado School of Mines 1500 Illinois Street Golden,CO80401	84-6000551	501c3	128,758	Junior Faculty
(87) Johns Hopkins University School of Medicine 733 North Broadway Baltimore,MD21205	52-0595110	501c3	115,000	Innovative Basic Science Precision Medicine
(88) Regents of the University of California 1111 Franklin Street 10th Floor Oakland,CA92093	95-6006144	501c3	115,000	Innovative Basic Science Precision Medicine
(89) Yale University 155 Whitney Avenue Room 230 PO Box New Haven,CT06510	06-0646973	501c3	115,000	Innovative Basic Science Precision Medicine
(90) University of Washington 1201 Larimer Street Seattle,WA99164	91-6001108	501c3	115,000	Innovative Basic Science Precision Medicine
(91) University of Massachusetts 333 South St Ste 450 Shrewsbury,MA02115	04-2774441	501c3	115,000	Innovative Basic Science Precision Medicine
(92) University of Washington 1201 Larimer Street Seattle,WA99164	91-6001108	501c3	115,000	Innovative Basic Science Precision Medicine
(93) Vanderbilt University Medical Center 3319 West End Avenue Ste 800 Nashville,TN37203	62-0476822	501c3	115,000	Innovative Basic Science Precision Medicine
(94) Benaroya Research Institute at Virginia Mason 1201 Ninth Avenue Seattle,WA98101	91-0653422	501c3	113,417	Innovative Basic Science Precision Medicine
(95) University of Pittsburgh 116 Atwood Street Suite 201 Pittsburg,PA15261	25-0965591	501c3	104,191	Junior Faculty Development
(96) The General Hospital Corporation dba Massachusetts General Hospital 55 Fruit Street Boston,MA01655	04-3167352	115	75,598	Postdoctoral Fellowship Precision Medicine
(97) Joslin Diabetes Center Inc One Joslin Place Boston,MA01655	04-3167352	115	71,308	Mentor-Based Postdoctoral Fellowship
(98) Children's Research Institute 111 Michigan Ave NW Washington,DC20010	52-1654453	501c3	70,780	Postdoctoral Fellowship Health Disparities Award
(99) Joan & Sanford I Weill Medical College of Cornell University 1300 York Ave New York,NY10065	15-0532082	501c3	69,780	Postdoctoral Fellowship Precision Medicine
(100) Beth Israel Deaconess Medical Center Inc 330 Brookline Ave Boston,MA02115	04-2774441	501c3	69,100	Mentor-Based Postdoctoral Fellowship
(101) Baylor College of Medicine One Baylor Plaza Houston,TX75284	75-6002868	170c1	67,500	ADA-Pfizer Fellowship Award
(102) Harvard Medical School 1033 Massachusetts Ave Third Floor Cambridge,MA01655	04-3167352	115	66,880	Mentor-Based Postdoctoral Fellowship
(103) University of Miami School of Medicine PO Box 025405 Miami,FL33102	59-0624458	501c3	66,712	New Postdoctoral Fellowship
(104) Joan & Sanford I Weill Medical College of Cornell University 1300 York Ave New York,NY10065	15-0532082	501c3	65,631	Postdoctoral Fellowship Precision Medicine
(105) Stanford University School of Medicine 3145 Porter Drive Palo Alto,CA94305	94-1156365	501c3	65,227	Postdoctoral Fellowship Precision Medicine
(106) City of Hope Beckman Research Institute 1500 East Duarte Road Duarte,CA94305	94-1156365	501c3	64,756	Mentor-Based Postdoctoral Fellowship
(107) The Children's Mercy Hospital 2401 Gillham Road Kansas City,MO64108	44-0605373	501c3	64,144	New Postdoctoral Fellowship
(108) University of Virginia 1001 N Emmet St Charlottesville,VA22904	54-6001796	501c3	64,142	New Postdoctoral Fellowship
(109) University of North Carolina at Chapel Hill 104 Airport Dr Ste 2200 CD1350 Chapel Hill,NC27157	22-3849199	501c3	63,760	New Postdoctoral Fellowship
(110) Partners Healthcare System Inc 399 Revolution Dr Ste 645 Somerville,MA021451465	04-2103561	501c3	63,760	New Postdoctoral Fellowship
(111) Joan and Sanford I Weill Medical College 1300 York Ave New York,NY10065	15-0532082	501c3	61,889	Investigator New to Diabetes Research Award
(112) Joslin Diabetes Center Inc One Joslin Place Boston,MA01655	04-3167352	115	60,760	Mentor-Based Postdoctoral Fellowship
(113) Board of Regents of the University of Wisconsin System 21 N Park Street Suite 6401 Madison,WI53226	39-0806261	501c3	60,760	Mentor-Based Postdoctoral Fellowship
(114) The General Hospital Corporation dba Massachusetts General Hospital 55 Fruit Street Boston,MA01655	04-3167352	115	58,533	Postdoctoral Fellowship Precision Medicine
(115) Northwestern University 633 Clark Street Evanston,IL60208	36-2167817	501c3	55,000	CDTR Award
(116) Kaiser Foundation Research Institute 1800 Harrison Street Oakland,CA94612	94-1105628	501c3	55,000	CDTR Award
(117) Kaiser Foundation Research Institute 1800 Harrison Street Oakland,CA94612	94-1105628	501c3	55,000	CDTR Award
(118) University of Michigan 3003 S State St Rm 1054 Ann Arbor,MI48202	38-6028429	501c3	54,880	CDTR Award
(119) Emory University 1599 Clifton Road Atlanta,GA30322	58-0566256	501c3	54,844	CDTR Award
(120) University of Colorado Denver 1800 Grant Street Suite 600 Denver,CO80203	84-6000555	501c3	54,718	CDTR Award
(121) Albert Einstein College of Medicine 1300 Morris Park Avenue Bronx,NY10461	47-2209056	501c3	54,704	CDTR Award
(122) Albert Einstein College of Medicine 1300 Morris Park Avenue Bronx,NY10461	47-2209056	501c3	54,006	CDTR Award
(123) Duke University 324 Blackwell St Washington Bldg Durham,NC27599	56-6001393	501c3	52,896	ADA-Pfizer Fellowship Award
(124) University of Michigan 3003 S State St Rm 1054 Ann Arbor,MI48202	38-6028429	501c3	49,153	Mentor-Based Minority Postdoctoral Fellowship
(125) University of Colorado Denver 1800 Grant Street Suite 600 Denver,CO80203	84-6000555	501c3	36,693	CDTR Award
(126) George Washington University Biostatistics Center 6110 Executive Blvd Rockville,MD20852	53-0196584	501c3	33,000	RISE Co-Support
(127) Emory University 1599 Clifton Road Atlanta,GA30322	58-0566256	501c3	32,870	CDTR Award
(128) University of Kansas Medical Center Research Institute Inc 3901 Rainbow Boulevard Kansas City,KS66160	48-1108830	501c3	10,000	Loan
(129) Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee,WI53226	39-0806261	501c3	10,000	Loan
(130) Arizona Board of Regents University of Arizona 2700 N Central Ave Suite 850 Phoenix,AZ85004	74-2652689	170c1	10,000	Loan
(131) University of Colorado 1800 Grant Street Suite 600 Denver,CO80203	84-6000555	501c3	10,000	Loan
(132) University of Miami 1252 Memorial Drive Coral Gables,FL33146	59-0624458	501c3	10,000	Loan
(133) Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee,WI53226	39-0806261	501c3	10,000	Student Loan
(134) The University of North Carolina at Chapel Hill 104 Airport Dr Ste 2200 CD1350 Chapel Hill,NC27157	22-3849199	501c3	10,000	Student Loan
(135) University of Wyoming 1000 East University Avenue Laramie,WY82071	83-6000331	501c3	8,000	Loan
(136) Northwestern University Medical School 420 E Superior St 9th Floor Chicago,IL60611	36-2167817	501c3	1,625,000	Early Investigator Award
(137) University of North Carolina at Chapel Hill 104 Airport Dr Ste 2200 CD1350 Chapel Hill,NC27157	22-3849199	501c3	1,622,683	Early Investigator Award
(138) Indiana University School of Medicine 107 S Indiana Avenue Bloomington,IN47405	35-6001673	501c3	325,000	Research Career Initiator
(139) Columbia University 615 West 131st Street MC 8741 New York,NY10065	13-1924236	501c3	325,000	Early Investigator Award
(140) University of Illinois at Urbana-Champaign 1305 West Green Street Urbana,IL61801	37-6006007	501c3	325,000	Investigator New to Diabetes Research Award
(141) Washington University 700 Rosedale Avenue Saint Louis,MO631121408	43-0653611	501c3	325,000	Early Investigator Award
(142) University of Notre Dame 724 Grace Hall Notre Dame,IN46556	35-0868188	501c3	325,000	Early Investigator Award
(143) University of Pennsylvania 3451 Walnut St P-221 Frankin Buildi Philadelphia,PA19104	23-1352685	501c3	325,000	Investigator New to Diabetes Research Award
(144) Dana-Farber Cancer Institute 450 Brookline Avenue Boston,MA02215	04-2263040	501c3	325,000	Early Investigator Award
(145) University of California San Francisco 3333 California Street Ste 315 San Francisco,CA94143	94-6036493	501c3	325,000	Investigator New to Diabetes Research Award
(146) The Jackson Laboratory 600 Main Street Bar Harbor,ME04609	01-0211513	501c3	324,977	Early Investigator Award
(147) University of Virginia 1001 N Emmet St Charlottesville,VA22904	54-6001796	501c3	305,000	Research Career Initiator
(148) Duke University 324 Blackwell St Washington Bldg Durham,NC27701	56-0532129	501c3	271,031	Research Career Initiator
(149) Joslin Diabetes Center One Joslin Place Boston,MA02215	04-2203836	501c3	225,000	Research Career Initiator

Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image

144

Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50055P

Schedule I (Form 990) 2022

Page 2

Part III

Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance	(b) Number of recipients	(c) Amount of cash grant	(d) Amount of noncash assistance	(e) Method of valuation (book, FMV, appraisal, other)	(f) Description of noncash assistance

(1) Lecture Honoraria	7	47,000
(2) Travel Scientific Conferences	3	1,953
(2)
(3)
(4)
(5)
(6)
(7)

Part IV

Supplemental Information. Provide the information required in Part I, line 2; Part III, column (b); and any other additional information.

Return Reference	Explanation
Part I Line 2	Related to Research The American Diabetes Association provides grant funding that aligns with the organizations mission and vision and, supports innovative scientific discoveries that translate to better treatment, healthier lives, and eventual cures. The American Diabetes Association closely monitors the use of all grant funds. Each grantee is required to submit an Annual Progress Report within a 60 day window of each previously committed funding year and is comprised of a scientific and a financial section. Each year of funding after the first is contingent upon approval of the Annual Progress Report and availability of funds. If the complete Report is not received within 90 days after the due date, payments will not be disbursed until all reporting requirements have been met and, the grant may be terminated. After completion of the final year of the grant, a Cumulative Final Report, which includes a scientific and financial section, is due within 60 days after the expiration date of the grant. If the complete final report is not received by the due date, the grantee will not be eligible to apply for any future American Diabetes Association Research awards until the obligations for the award are complete. This process is monitored and reviewed by the American Diabetes Association Science and Health Care Management Team for award status and compliance.
Part I Line 2	Related to Camps The American Diabetes Association continues to be the worlds largest provider of camps for children with diabetes to help ensure the wellbeing of families affected by diabetes. The Association provides grants, scholarships and targeted youth programs for persons with diabetes. Each summer, thousands of children have the opportunity to spend time at Diabetes Camp, meeting other children with diabetes and sharing their experiences, challenges, hopes, and dreams. In 2022, the American Diabetes Association hosted 25 camp sessions in 25 states serving 3,000 campers with Type I, and over 3,000 participants at risk for Type 2 diabetes. In addition, more than 1,500 volunteers made camp possible by donating their time and expertise. Camp provides an outdoor recreational experience in which the child for children with diabetes ages 4 to 17 can develop as a person while including informal education about the management of diabetes. Children are carefully supervised by a staff of doctors, nurses, dietitians, and other volunteers and staff. Program Evaluation and outcome measurement provide valuable data to the Association regarding camp programs and how to improve them. An assessment/planning meeting including camp volunteers and staff leadership is held within two months of the conclusion of the camp season. At this time, camp results are evaluated and compared to goals. The strengths and weaknesses of the camp program, opportunities for growth and improvement, emerging issues and needs and the viability of continuation initiation of new programs are evaluated.
Part I Line 2	Related to Education The American Diabetes Association is committed to preventing diabetes. The Diabetes Prevention Program DPP was a major multicenter clinical research study aimed at discovering whether modest weight loss through dietary changes and increased physical activity or treatment with the oral diabetes drug metformin Glucophage could prevent or delay the onset of type 2 diabetes in study participants. The DPP found that participants who lost a modest amount of weight through dietary changes and increased physical activity sharply reduced their chances of developing diabetes. Taking metformin also reduced risk, although less dramatically. The DPPs results indicate that millions of high-risk people can delay or avoid developing type 2 diabetes by losing weight through regular physical activity and practicing healthy eating. Weight loss and physical activity lower the risk of diabetes by improving the bodys ability to use insulin and process glucose. The DPP contributed to a better understanding of how diabetes develops in people at risk and how they can prevent or delay the development of diabetes by making behavioral changes leading to weight loss. These findings are reflected in recommendations from the American Diabetes Association for the prevention or delay of type 2 diabetes, which stress the importance of lifestyle changes and weight loss. Building on the success of the DPP, the Centers for Disease Control and Prevention CDC led National Diabetes Prevention Programs Lifestyle Change Program is an evidence-based lifestyle change program for preventing or delaying type 2 diabetes. The year long program helps participants make real lifestyle changes such as eating healthier, including physical activity into their daily lives, and improving problem solving and coping skills.
Part III Line 1,2	Each year, the American Diabetes Association recognizes the outstanding contributions of individuals in the service of the diabetes community through its National Achievement Awards. These awards are among the Associations most noteworthy and coveted recognition opportunities, celebrating those whose significant contributions to our cause have been national in scope and impact. Past recipients represent individuals or groups that have never faltered in their efforts to improve the lives of all people affected by diabetes.

Schedule I (Form 990) 2022

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

- TIN:

Schedule J
(Form 990)

Department of the Treasury
Internal Revenue Service

Compensation Information

For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet

Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
SchJMediumBullet

Attach to Form 990.
SchJMediumBullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2022

Open to Public Inspection

Name of the organization

American Diabetes Association

Employer identification number

13-1623888

Part I

Questions Regarding Compensation

Yes

Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.

First-class or charter travel Housing allowance or residence for personal use

Travel for companions Payments for business use of personal residence

Tax idemnification and gross-up payments Health or social club dues or initiation fees

Discretionary spending account Personal services (e.g., maid, chauffeur, chef)

If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .....

Yes

Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a? ....

Yes

Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.

Compensation committee Written employment contract

Independent compensation consultant Compensation survey or study

Form 990 of other organizations Approval by the board or compensation committee

During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:

Receive a severance payment or change-of-control payment? .............

Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........

Yes

Participate in, or receive payment from, an equity-based compensation arrangement? .........

If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.

Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:

The organization? ....................

Any related organization? .......................

If "Yes," on line 5a or 5b, describe in Part III.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:

The organization? ..................

Any related organization? ......................

If "Yes," on line 6a or 6b, describe in Part III.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............

Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................

If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50053T

Schedule J (Form 990) 2022

Page 2

Part II

Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.

For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.

(A) Name and Title		(B) Breakdown of W-2, 1099-MISC compensation, and/or 1099-NEC			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation in column (B) reported as deferred on prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)
1Charles D Henderson Effective May 1 Chief Executive Officer	(i) (ii)	455,034 -------------	154,000 -------------	1,301 -------------	194,048 -------------	1,031 -------------	805,414 -------------	-------------
2Charlotte M Carter Chief Financial Administrative Officer	(i) (ii)	329,323 -------------	59,049 -------------	2,389 -------------	31,801 -------------	10,597 -------------	433,159 -------------	-------------
3Robert A Gabbay Chief Scientific Medical Officer	(i) (ii)	481,835 -------------	91,126 -------------	6,922 -------------	48,767 -------------	20,264 -------------	648,914 -------------	-------------
4Alana Seger SVP Field Revenue Operations	(i) (ii)	183,807 -------------	-------------	4,320 -------------	7,155 -------------	30,193 -------------	225,475 -------------	-------------
5Sean C McDonough Senior Vice President General Counsel	(i) (ii)	225,511 -------------	-------------	2,986 -------------	22,348 -------------	956 -------------	251,801 -------------	-------------
6Nuha El Sayed Vice President, Health Care Improvement	(i) (ii)	200,462 -------------	-------------	2,027 -------------	1,133 -------------	876 -------------	204,498 -------------	-------------
7Kelly A Mueller Senior Vice President, Strategy	(i) (ii)	186,857 -------------	7,000 -------------	3,549 -------------	7,586 -------------	1,835 -------------	206,827 -------------	-------------
8Lisa A Murdock Chief Advocacy Officer	(i) (ii)	191,000 -------------	-------------	1,840 -------------	13,010 -------------	10,185 -------------	216,035 -------------	-------------
9Laura B Hieronymus Vice President, Health Care Programs	(i) (ii)	188,560 -------------	-------------	3,473 -------------	1,172 -------------	10,171 -------------	203,376 -------------	-------------

Schedule J (Form 990) 2022

Page 3

Part III

Supplemental Information

Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.

Return Reference	Explanation
Part I Line 1a	Payments related to additional pension benefits are grossed up for individual tax reporting purposes.
Part I Line 4b	Charles D. Henderson, Chief Executive Officer, is compensated by the American Diabetes Association and contributed 38,486 to its supplemental 457f retirement plan.
Part I Line 4b	Charlotte M. Carter, Chief Financial Administrative Officer, is compensated by the American Diabetes Association and contributed 18,397 to its supplemental 457f retirement plan.
Part I Line 4b	Robert A. Gabbay, Chief Scientific Medical Officer, is compensated by the American Diabetes Association and contributed 31,939 to its supplemental 457f retirement plan.
Part I Line 4b	Sean McDonough, Senior Vice President General Counsel, is compensated by the American Diabetes Association and contributed 13,686 to its supplemental 457f retirement plan.
Part I Line 4b	Lisa Murdock, Chief Advocacy Officer, is compensated by the American Diabetes Association and contributed 5,499 to its supplemental 457f retirement plan.

Schedule J (Form 990) 2022

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

- TIN:

Schedule L
(Form 990)

Department of the Treasury
Internal Revenue Service

Transactions with Interested Persons

Complete if the organization answered "Yes" on Form 990, Part IV, lines 25a, 25b, 26, 27, 28a, 28b, or 28c, or Form 990-EZ, Part V, line 38a or 40b.
MediumBullet

Attach to Form 990 or Form 990-EZ.
MediumBullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2021

Open to Public Inspection

Name of the organization

American Diabetes Association

Employer identification number

13-1623888

Part I

Excess Benefit Transactions (section 501(c)(3), section 501(c)(4), and section 501(c)(29) organizations only).
Complete if the organization answered "Yes" on Form 990, Part IV, line 25a or 25b, or Form 990-EZ, Part V, line 40b.

1(a) Name of disqualified person	(c) Description of transaction	(d) Corrected?
1(a) Name of disqualified person	(c) Description of transaction	Yes	No

Enter the amount of tax incurred by the organization managers or disqualified persons during the year under section 4958. ........................... Bullet Image

Enter the amount of tax, if any, on line 2, above, reimbursed by the organization ........ Bullet Image

Part II

Loans to and/or From Interested Persons.
Complete if the organization answered "Yes" on Form 990-EZ, Part V, line 38a, or Form 990, Part IV, line 26; or if the organization reported an amount on Form 990, Part X, line 5, 6, or 22

(a) Name of interested person	(b) Relationship with organization	(c) Purpose of loan	(d) Loan to or from the organization?		(e) Original principal amount	(f) Balance due	(g) In default?		(h) Approved by board or committee?		(i) Written agreement?
(a) Name of interested person	(b) Relationship with organization	(c) Purpose of loan	To	From	(e) Original principal amount	(f) Balance due	Yes	No	Yes	No	Yes	No






Total ............... $

Part III

Grants or Assistance Benefiting Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 27.

(a) Name of interested person	(b) Relationship between interested person and the organization	(c) Amount of assistance	(e) Purpose of assistance
(1) Layla A Abushamat MD	Grant Review Committee Member	67,500	ADA-Pfizer Fellowship Award
(2) Rachel Goode PhD	Grant Review Committee Member	199,877	Innovative Clinical or Translational Science New Health Disparities
(3) Anjali Gopalan MD	Grant Review Committee Member	199,818	Innovative Clinical or Translational Science New Health Disparities
(4) Michelle L Litchman PhD	Grant Review Committee Member	200,000	Innovative Clinical or Translational Science Health Disparities
(5) Jordi Merino PhD	Grant Review Committee Member	134,059	Junior Faculty
(6) Rachel G Miller PhD	Grant Review Committee Member	104,191	Junior Faculty Development
(7) Rochelle Naylor MD	Grant Review Committee Member	196,259	Innovative Clinical/Translational Science Precision Medicine
(8) Deirdre Kay Tobias DSc	Grant Review Committee Member	196,859	Innovative Clinical or Translational Science Nutrition
(9) Eva Marie Vivian PharmD PhD	Grant Review Committee Member	194,500	Innovative Clinical or Translational Science New Health Disparities
(10) Rebekah J Walker PhD	Grant Review Committee Member	137,836	Junior Faculty Development
(11) Rebekah J Walker PhD	Grant Review Committee Member	10,000	Student Loan

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 50056A

Schedule L (Form 990) 2021

Page 2

Part IV

Business Transactions Involving Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 28a, 28b, or 28c.

(a) Name of interested person	(b) Relationship between interested person and the organization	(c) Amount of transaction	(d) Description of transaction	(e) Sharing of organization's revenues?
(a) Name of interested person		(c) Amount of transaction	(d) Description of transaction	Yes	No
(1) Stephanie Silverman	Director	973,803	Government Relations Consulting		No

Part V

Supplemental Information
Provide additional information for responses to questions on Schedule L (see instructions).

Return Reference

Explanation

Part IV Line 1

The American Diabetes Association hired Venn Strategies to provide government relations consulting services. Stephanie Silverman, the Chief Executive Officer of Venn Strategies, served on the Board of Directors of the American Diabetes Association in 2022. This service relationship was reviewed and approved pursuant to the ADAs conflict of interest policy. As a result of this review, Ms. Silverman recused herself from board actions that could be perceived as a conflict of interest.

Schedule L (Form 990) 2021

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

- TIN:

SCHEDULE M
(Form 990)

Department of the Treasury

Internal Revenue Service

Noncash Contributions

Complete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image

Attach to Form 990.
Right pointing arrow large image

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2022

Open to Public Inspection

Name of the organization

American Diabetes Association

Employer identification number

13-1623888

Part I

Types of Property

	(a) Check if applicable	(b) Number of contributions or items contributed	(c) Noncash contribution amounts reported on Form 990, Part VIII, line 1g	(d) Method of determining noncash contribution amounts
1 Art—Works of art ....
2 Art—Historical treasures .
3 Art—Fractional interests ..
4 Books and publications ..
5 Clothing and household goods .......
6 Cars and other vehicles ..	X	497	458,450	See Part II
7 Boats and planes ....
8 Intellectual property ...
9 Securities—Publicly traded .	X	46	1,953,343	Fair Market Value
10 Securities—Closely held stock .
11 Securities—Partnership, LLC, or trust interests ....
12 Securities—Miscellaneous ..
13 Qualified conservation contribution—Historic structures .....
14 Qualified conservation contribution—Other ...
15 Real estate—Residential .
16 Real estate—Commercial ..
17 Real estate—Other ...
18 Collectibles .....
19 Food inventory ...
20 Drugs and medical supplies .	X	35,526	1,628,866	Fair Market Value
21 Taxidermy ......
22 Historical artifacts ....
23 Scientific specimens ..
24 Archeological artifacts ...
25 Other ( )
26 Other ( )
27 Other ( )
28 Other ( )

Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement

Yes

30a

During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that it must hold for at least three years from the date of the initial contribution, and which isn't required to be used for exempt purposes for the entire holding period? ...................

30a

If "Yes," describe the arrangement in Part II.

Does the organization have a gift acceptance policy that requires the review of any nonstandard contributions?

Yes

32a

Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash

contributions? ..........................

32a

Yes

If "Yes," describe in Part II.

If the organization didn't report an amount in column (c) for a type of property for which column (a) is checked,

describe in Part II.

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 51227J

Schedule M (Form 990) (2022)

Page 2

Part IISupplemental Information. Provide the information required by Part I, lines 30b, 32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.

Return Reference	Explanation
Part I Line 6	The method of determining noncash contribution amounts is the sales of comparable property and/or opinion of expert to determine the fair market value.
Part I Line 32b	The American Diabetes Association contracts with Charitable Adult Rides and Services, Inc., 4669 Murphy Canyon Road, Suite 200, San Diego, CA 92123, to advertise for donation of vehicles, as well as receive and sell/dispose of the donated vehicles on behalf of the American Diabetes Association.
Part I Line 6,9,20	Column b reports the number of items contributed.

Schedule M (Form 990) (2022)

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

- TIN:

SCHEDULE O
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.
MediumBullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2021

Open to Public
Inspection

Name of the organization

American Diabetes Association

Employer identification number

13-1623888

Return Reference	Explanation
Form 990, Part III, Line 4	Connected for Life. Today, more than 133 million Americans in the United States have diabetes or prediabetes an invasive, unrelenting, and debilitating disease that spans all ages, geographic areas, and education levels. This chronic disease affects children, the elderly, and minority populations more than others and costs the United States 327 billion each year. It is a global epidemic that contributes to heart disease, stroke, nerve and kidney disease, and vision loss. The American Diabetes Association ADA is the only organization dedicated specifically to the research, education, and advocacy required to improve the lives of over 37 million adults and children in the U.S. with diabetes and the 96 million American adults with prediabetes. For over 80 years, we have been working on the front lines to educate at risk populations protect the rights of people with diabetes at work, school, and other aspects of daily life pioneer clinical and research breakthroughs and foster a pipeline of the best and brightest scientists. In recent years, our mission has taken on new urgency, as the COVID 19 pandemic shined a very bright spotlight on diabetes as a public health crisis and on the severe health inequities in our country. The ADA quickly adapted our research focus, resources, programs, and events in service to people living with diabetes and the health care professionals who treat them. In 2022 we continued to support critical research, advocate for affordable health care, and convene the worlds leading scientists to find new ways to tackle diabetes.
Form 990, Part III, Line 4	The moving force behind the work of the ADA is a network of more than 400,000 volunteers, their families and caregivers, a professional society of nearly 12,000 health care professionals, as well as more than 250 staff members. From research labs to the halls of the Capitol, to the offices of health care practitioners to communities nationwide, the ADA is there. We are bending the curve to help people living with diabetes and their families thrive. Why Because our vision is a life free of diabetes and all its burdens, which is fueled by our mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. DIABETES RESEARCH. Support the Highest Quality Science. Diabetes is an extremely complex disease, caused by a combination of various genetic and environmental factors that lead to an inability to produce or effectively use insulin. This leads to higher blood glucose blood sugar levels that are eventually high enough to be considered diabetes. The complex number of causes and individuality of each persons diabetes makes finding a cure particularly difficult, and its expected that more than one will be needed. While a cure has been elusive, critical research efforts in recent decades have led to significantly improved care for people with diabetes, resulting in better health outcomes and fewer complications for people with diabetes.
Form 990, Part III, Line 4	The ADA funds critical, innovative diabetes research and invests in promising scientists early in their careers. Our leadership in diabetes research extends back to the 1940s when Dr. Charles H. Best, one of four scientists credited with discovering insulin, provided the ADA with the framework and early leadership for a formalized diabetes research program. Since the ADA started its Research Program in 1952, we have invested approximately 950 million in innovative diabetes research projects. In 2022 alone, we supported over 140 active research projects and awarded 82 new grants. All these projects were dedicated to progressing the fight against diabetes, and many were led by early career investigators. While we have learned much about diabetes, there is so much left to discover. The primary goals of the ADAs Research Program are to Support the highest quality science across the broad spectrum of diabetes research. Support investigators early in their careers to encourage them to dedicate their efforts to diabetes research. Support innovative research with a high potential to have a significant impact for patients with diabetes and move those discoveries into practice.
Form 990, Part III, Line 4	Peer Review Process. One of the factors that sets ADA funded research apart and ensures we are supporting the very best science, is peer review. Peer review is a process whereby grant applications are reviewed and evaluated by individuals who are experts in the field peers of the individual submitting the grant. ADA grant applications undergo peer review by three or more volunteer experts who are experienced researchers. Reviewers provide both a score and detailed comments regarding the strengths and weaknesses of each grant they review. Scores from all reviewers for each grant are averaged to arrive at a composite merit score that is used to determine which grants to support. Our Research Approach. About two years ago, the ADA refocused our longstanding research program, allowing us to respond more quickly to the most mission-critical needs in diabetes prevention and care, and accelerate innovations ready for expansion. This strategy has been met with much enthusiasm and is growing in size and stature. In addition to our standard grant cycles, in 2022 we partnered with the National Institute of Diabetes and Digestive and Kidney Diseases NIDDK to support next generation researchers in the Centers for Diabetes Translation Research, which aim to improve the translation of research findings related to diabetes prevention, treatment, and health equity.
Form 990, Part III, Line 4	Another 2022 highlight was the Health Disparities Grantee Workshop in Washington, DC, which brought together ADA research grantees for collaboration, project reporting, and exposure to future funding opportunities with NIDDK program officers. This workshop will become our model moving forward as we convene ADA funded researchers to foster cross pollination and a collaborative spirit throughout the field of diabetes. Restarting Pathway. This year we restarted our Pathway to Stop Diabetes Pathway awards program, after a pause due to the COVID19 pandemic. Pathway is a revolutionary five year grant designed to transform diabetes research by attracting innovative scientists, physicians, and researchers through financial support and professional mentorship. The program funds this new generation of scientists 36 to date at the peak of their creativity, providing them with the freedom, autonomy, and resources to discover the next breakthroughs in the field of diabetes. For the first time in Pathways history, in 2022 we diversified our strategy to emphasize translational research while continuing to support basic science projects. Our newest awardees are Anna Kahkoska, MD, PhD, Gillings School of Public Health, University of North Carolina at Chapel Hill, Project Fusing rapid cycle testing and adaptive interventions A scientific pipeline to translate and individualize evidence based psychosocial and behavioral interventions in routine type 1 diabetes care.
Form 990, Part III, Line 4	Lisa Beutler, MD, PhD, Northwestern University Medical School, Project Dissecting sugar induced modulation of gut brain circuits This project seeks to understand how sugar consumption alters the connection between the gut and the brain, and how this may link to obesity and type 2 diabetes. For more information, view our 2022 Research Report. Scientific Sessions. Held annually, Scientific Sessions is the worlds largest scientific and medical meeting focused on the latest basic and clinical science research related to diabetes and its complications. The meeting exemplifies the ADAs leadership role in the global diabetes community while providing a critical platform for driving diabetes awareness. In June 2022, the ADA hosted the first hybrid Scientific Sessions from New Orleans, LA, providing a broader reach than ever for the worlds premier meeting on diabetes research, prevention, and care. The enthusiasm was palpable as leading diabetes scientists and health care professionals gathered to present, learn, and discuss the most recent findings and to network with their friends and colleagues in person. Notable presentation topics included COVID19, mental health, adolescent health, and advocacy. The 82nd Scientific Sessions by the numbers 10,000 attendees, 116 countries represented, 193 educational sessions, 1,200 published posters, 80 exhibitors
Form 990, Part III, Line 4	INFORMATION. Saving Lives Through Knowledge. For people affected by or at risk for diabetes, having access to the most up to date tools and resources can literally make the difference between life and death. As a trusted leader, the ADA works to ensure those affected by and at risk for diabetes, their health care team, and the public receive targeted, timely, and accurate information. We deliver resources people can access at any time in multiple formats including our website for consumers diabetes.org, our flagship social media channels, and our professional journals and publications. We focus our efforts on three areas Raising awareness of diabetes as a serious disease. Ensuring patients, providers, and caregivers have tools and resources to effectively treat and manage diabetes. Reaching diverse groups of people who are at risk for or have diabetes, their families, and health care professionals, with the goal of reducing the incidence of diabetes and the impact of complications. Center for Information. The ADAs Center for Information CFI can be reached at 1 800 DIABETES 1 800 342 2383. The CFI marks the first stop for many of our constituents as they start their journey of living with diabetes. The CFI helps to bend the curve every day by providing constituents with information and resources on prevention, nutrition, and diabetes management medications and supplies discrimination issues ADA events assisting professional members and donors and much more. With every touchpoint, our CFI team takes pride in being helpful, respectful, and kind.
Form 990, Part III, Line 4	In 2022, the CFI supported the ADAs mission by Processing nearly 50,000 contacts from constituents, professional members, and others. Collecting 145,606 in donations. Pointing constituents to our digital resources online and epackets and manually processing and mailing packets of literature to those without internet access. Hosting live agent chats to provide constituents with real time access to CFI staff, should questions arise while browsing diabetes.org. Processing 1,206 intakes for our Legal Advocacy team. Providing five percent of all CFI inquiries with information and resources for assistance with diabetes medications and supplies. We continued our working relationships with Novo Nordisk and Eli Lilly to connect constituents who need financial assistance for their insulin directly to the Novo Nordisk Customer Care Center and the Lilly Diabetes Solution Center. In addition, we fostered a relationship with Patient Advocate Foundations Co Pay Relief program to provide direct financial assistance to those who meet eligibility requirements. Digital Engagement. We maintain a strategic suite of digital channels to connect with our consumer and professional audiences while providing the latest diabetes related information and news. From our website diabetes.org to our blog diabetes.org blog to our ever growing presence on Facebook, Twitter, YouTube, and Instagram, the ADA is connected to its constituents 24 7.
Form 990, Part III, Line 4	Our Consumer Website. Our website for consumers, diabetes.org, is widely regarded as the most informative and credible diabetes and nutrition resource online. In 2022, the site had 12.7 million sessions, 18.3 million unique pageviews, and 9.8 million new users. Social Media. The ADAs flagship social media channels continued to grow in 2022 Facebook follower base exceeds 794,000. Twitter following exceeds 143,000. Instagram following exceeds 62,000. LinkedIn continues to be a dedicated marketing communications channel for the professional audience. Our company page has more than 92,000 followers. We also maintain social media communities for health care professionals on Facebook 40,000 followers and Twitter more than 21,000 followers. Our Professional Website. Our website for professionals, professional.diabetes.org, provides the latest resources in diabetes care and research for health care professionals and scientists. Through this mobile friendly platform, the ADA delivers enhanced and customized content as well as access to members only benefits. DiabetesPro is the most advanced collection of diabetes resources available to professionals, providing them with a convenient way to stay informed.
Form 990, Part III, Line 4	Featured content includes News via DiabetesPro SmartBrief, which has over 50,000 subscribers. Diabetes meetings and continuing education opportunities, including the ADAs Scientific Sessions, Clinical Update Conference, and online interactive programs. Clinical practice recommendations, including the Standards of Care in Diabetes. Webcasts and podcasts, including Diabetes Core Update. Journals and books. DiabetesPro Quarterly, our quarterly membership enewsletter, with about 16,000 subscribers. Professional Member Interest Group resources, including our DiabetesPro Member Forum, an online community with more than 18,000 professional users. Research grant information, including funding cycle information and funded research. Diabetes Education Recognition Program ERP information and resources. Professional Education. The primary goal of the ADAs professional education program is to ensure excellent treatment and improve patient outcomes for people with diabetes by providing quality education for all health care professionals on the diabetes management team. The ADA has been accredited to provide continuing education to health care professionals for more than 30 years and is a Joint Accredited Provider. We conduct professional education activities directed toward enhancing knowledge and competence, advancing skills, and apprising health care professionals of the latest developments in diabetes research and clinical practice.
Form 990, Part III, Line 4	Our professional education programs were transformed in 2022 through the utilization of new educational technologies available to enhance learning. The Professional Education Portal provides on demand learning with interactive elements to meet the needs of busy clinicians. Learners can earn certificates of completion from popular programs including Diabetes Is Primary, Making Diabetes Technology Work, Diabetes Education 101 for the Behavioral Health Professional, and Behavioral Health in Diabetes Care. Professional Membership. In 2021 the Professional Membership team began the process of identifying a new database platform that would give the ADA a 360 degree view of all professional constituents and significantly improve the member experience. The new platform, Nimble, went live in November 2022 and provides greater efficiencies for ADA staff and professional users. Going forward, the ADA will be able to offer professional members auto renewal recurring billing. Additionally, Nimble enables visitors to professional.diabetes.org to use other ADA websites with a single username and password. It will also simplify the committee application process along with housing their conflict of interest information in one place.
Form 990, Part III, Line 4	Professional Engagement. In 2022, the ADAs volunteer leadership teams accelerated efforts to provide virtual career development and networking opportunities to our professional constituents. The Professional Membership Interest Groups and the Womens Interprofessional Network of the American Diabetes Association WIN ADA elevated the research being presented at the 82nd Scientific Sessions by recognizing 15 researchers and their abstracts. The Membership Advisory Group showcased this research in a webinar post meeting for those unable to attend. Also at the 82nd Scientific Sessions, the Professional Membership Interest Groups and WIN ADA hosted over 300 ADA members at in person networking events. WIN ADA hosted the first cohort of 25 early to mid career women in their member exclusive professional development course. Our interest groups hosted more than 18 exclusive webinars reaching 1,318 professionals, allowing the groups to foster knowledge and share research updates among members throughout the year. The interest groups and WIN ADA cultivated community through open discussion among like minded professionals with 340 new discussion threads and 534 discussion responses on the DiabetesPro Member Forum. The Focus on Fellows program met in person at the 82nd Scientific Sessions in June. A total of 55 endocrine fellows participated in 25 interactive sessions focused on practical issues such as resumes, career paths, and identifying mentors.
Form 990, Part III, Line 4	The Hands On Webinar Series, a program that provides tips to improve diabetes care, completed its third and final year in 2022. Year three webinars drew an attendance of 2,245. This number was comprised of 1,511 unique professional attendees, more than a third of whom attended multiple sessions. Over the course of all three years, 33 webinars drew a total attendance of 7,422. Education Recognition Program. Since 1986 the ADAs Education Recognition Program ERP has been responsible for evaluating and recognizing diabetes self management education and support DSMES services nationwide. In February 2022, the ERP team, aided by experts and collaborating organizations from across the diabetes community, published the National Standards for Diabetes Self Management Education and Support. These standards, updated every five years, provide guidance and evidence-based quality practice for all DSMES services. This edition includes a focus on embracing cultural differences, social determinants of health, and technological advancements that help improve equitable access to DSMES services for people with diabetes. Throughout 2022, the ADAs ERP team conducted multiple symposiums aimed at helping ERP programs stay updated on the latest advances in diabetes care in alignment with the National Standards for DSMES and ADAs Standards of Care in Diabetes.
Form 990, Part III, Line 4	National Diabetes Prevention Program. The evidence based lifestyle change program known as the National Diabetes Prevention Program National DPP is the gold standard in preventing type 2 diabetes. The ADA is committed to promoting Centers for Disease Control and Prevention CDC recognized lifestyle change programs and improving access for the 96 million Americans with prediabetes, as it is important for everyone who has prediabetes to have an opportunity to prevent or delay type 2 diabetes. As part of this commitment, the ADA has worked with the CDC on a five year cooperative agreement. In 2022, the ADA was granted a one year extension of our work supporting affiliate sites in underserved areas across the country. Through this work, the ADAs DPP team has worked to improve retention in the lifestyle change program through the Dropout Study, which examined why participants do not complete the program and what programs can do to retain them. The findings of this study were presented at the Association of Diabetes Care Education Specialists annual conference ADCES22 in August 2022. Another key component to a successful National DPP lifestyle change program is effective data management and reporting. The ADA prioritizes quality data management and reporting and supports lifestyle change programs and networks by providing a user-friendly data collection and reporting platform called DPP Express. DPP Express not only allows programs to collect and report required data, but also ensures they can make data driven decisions making their programs as effective and efficient as possible.
Form 990, Part III, Line 4	In 2022, the ADA launched functionality that would allow medical billing and claims to be processed directly in the DPP Express platform. No longer are lifestyle change programs required to have a billing department to receive reimbursement for National DPP services. They can now simply submit reimbursable claims in the same place where they collect data. This will provide a cost effective way for smaller community based organizations to bill for DPP services. Diabetes Support in the Community. Through the Pfizer Foundations Health Equity Grant focused on addressing social determinants of health in Black communities, the ADA continues to work with community partners to expand the 10 acre community garden we created in Montgomery, AL, and has established a second community garden in Tampa, FL, to increase access to healthy foods and diabetes support in the community. Community Health Workers. To address the ADAs Standards of Care in Diabetes highlighting the importance of community health workers CHWs in diabetes prevention and management, especially among underserved communities, our National Health Disparities Committee has continued to provide oversight of CHW webinar training development and CHW resources featured on the Community Health Worker section of our website.
Form 990, Part III, Line 4	In 2022, the ADA also continued to partner with the National Center for Farmworker Health as part of a Health Resources and Services Administration-funded grant to deliver professional education opportunities. We also participated in the in-person and virtual forum for Migrant and Community Health, reaching over 1,000 health care professionals and CHWs nationwide. Overcoming Therapeutic Inertia. Despite advances in guidelines and therapies over the last two decades, data show that fewer people with diabetes are achieving an A1C under seven percent. One explanation for this problem is therapeutic inertia a delay or inaction to initiate or intensify therapy when glycemic treatment goals are not met. The ADAs Overcoming Therapeutic Inertia initiative OTI seeks to better understand and address the factors that contribute to therapeutic inertia in diabetes care. If we can overcome therapeutic inertia and manage blood glucose levels early in a persons diabetes journey, as recommended in the ADAs Standards of Care in Diabetes, it will reduce their risk of developing complications and lead to better long term outcomes.
Form 990, Part III, Line 4	In 2022, we Introduced the OTI Certificate Program to empower health care professionals to master strategies that will help patients overcome therapeutic inertia. Developed a new Patient Engagement Toolkit and Practice Improvement Resources, which have been downloaded nearly 3,200 times. Developed infographics for people with diabetes on deintensifying insulin and simplifying diabetes treatment plans. Updated relevant information in the ADA Consumer Guide, which has been accessed by more than 67,000 people to date. Funded a three arm pragmatic randomized control trial to evaluate the effects of physician education regarding therapeutic inertia, with and without proactive outreach by a non-physician clinician, on the achievement of glycemic targets at six months. Developed a practice guide tool for clinicians in small-to-medium sized health care practices to identify and intervene in the care of patients who might be experiencing therapeutic inertia. Supporters Sanofi, Novo Nordisk, Merck, AstraZeneca. Making Diabetes Technology Work. Technology has been a game-changer for diabetes management, and the ADA is dedicated to making these devices, apps, and other tools work harder for the people who need them.
Form 990, Part III, Line 4	Making Diabetes Technology Work focuses on educating health professionals and people with diabetes on how to incorporate these cutting-edge technologies into disease management. With knowledge of available technology, providers can better match their patients with the right tools to reach their blood glucose and other targets. Similarly, people with diabetes can learn how to use diabetes tech and data to streamline their day to day and improve their health outcomes. In 2022, we introduced and enhanced several program resources including nine new elearning modules which attracted over 2,300 participants as well as a webinar and self-assessment program for health care professionals who treat people with diabetes. Supporters Abbott Diabetes Care, LifeScan Mental Health. Diabetes is one of the hardest chronic diseases to manage, requiring people to constantly monitor their blood glucose levels, meals, activities, and mood. Because of this emotional drain, distress and depression are much more common in people with diabetes than people who do not have diabetes. And yet, mental health remains an overlooked topic in diabetes care.
Form 990, Part III, Line 4	To address the mental health burden of diabetes, the ADA maintains a Mental Health Professional Directory a vetted list of 269 licensed practitioners who have specialized training in diabetes related issues. In addition, there are resources for practitioners such as the Diabetes and Emotional Health Workbook and a Mental Health Toolkit to help integrate mental health into diabetes care. These resources were downloaded more than 5,300 times in 2022. Also in 2022 546 mental health professionals completed the updated Diabetes Education 101 for the Behavioral Health Professional elearning course. 479 people completed the new elearning course, Behavioral Health in Diabetes Care, which is for certified diabetes care and education specialists, social workers, and other members of the diabetes care team. Supporter The Leona M. and Harry B. Helmsley Charitable Trust. Womens Health. Up to 10 percent of pregnancies in the U.S. are affected by gestational diabetes every year, a condition that can adversely affect women and their babies later in life. In fact, 50 percent of people with gestational diabetes go on to develop type 2 diabetes and the risk for adverse outcomes doubles for Black and Hispanic women.
Form 990, Part III, Line 4	With the support of Karp Randel, the ADA launched the Womens Health Initiative in 2022 to enhance prevention, appropriate and timely treatment, and education around gestational diabetes and improve outcomes for both mother and child. These efforts included Recruiting health system partners for quality improvement and best practice sharing. Conducting focus groups with community health workers and doulas. Establishing a Scientific Advisory Council to contribute strategic insight and collaborate on education programs. In 2023, we plan to scale the Womens Health Initiative by Facilitating learning collaborative meetings with health system partners to improve baseline data. Conducting focus groups with midwives and women with gestational diabetes. Developing four education modules on gestational diabetes basics, treatments, technology, and health equity. Time in Range. The Time in Range TIR initiative focuses on teaching health care professionals and their patients how to use data from blood glucose meters and continuous glucose monitors CGMs to make treatment and lifestyle decisions. TIR measures the amount of time blood glucose levels are on target between 70 and 180 mg dL for most people. And its more than a number, its a means to improve both the daily quality of life and long term outcomes for people with diabetes.
Form 990, Part III, Line 4	In 2022, with the support of Abbott Diabetes Care and LifeScan, the ADA introduced a suite of new TIR resources 12 Practice Pearl videos, 3 podcasts, 5 webinars, 14 infographics, Gamified case study competition for clinicians. Health care professionals engaged more than 27,000 times with these TIR resources, which covered topics ranging from managing TIR in pregnancy to reducing barriers to diabetes technology for diverse populations. Supporters Abbott Diabetes Care, LifeScan. Diabetes INSIDE. In 2022, Diabetes INSIDE continued to impact the lives of people living with type 2 diabetes and cardiovascular disease by focusing on quality improvement work in the Know Diabetes by Heart initiative with health system partners in the Greater Philadelphia, Mid Atlantic, and Chicago regions that target high risk African American and Latino populations. Through Diabetes INSIDE, primary care and university-based clinic staff attended quality improvement education workshops, as well as collected and analyzed data to identify trends and gaps in care and to monitor for change as we facilitated improvement projects across a wide range of operational, system, and clinical challenges.
Form 990, Part III, Line 4	In 2023, the ADA will be expanding the Diabetes INSIDE Know Diabetes by Heart initiative to additional health system partners. We also plan to expand Diabetes INSIDE quality improvement methodology into new initiatives focusing on improving care for pregnant moms with gestational diabetes in the New York City area, as well as eye care for people living with diabetes in urban and rural Alabama. PUBLICATIONS. Promoting Best Practices. Journals. ADA journals provide more than 40,000 researchers, physicians, and diabetes care specialists with the latest information on scientific research and clinical practice. The ADAs four highly respected professional journals, Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum, publish original research, consensus reports, scientific statements, and more, in addition to supplemental issues including the ADAs clinical practice guidelines the Standards of Care in Diabetes. In 2022, our journals received more than 13 million page views from five million unique users at diabetesjournals.org, and ADA published studies were cited more than 157,000 times, roughly an eight percent increase over 2021. Also this year, Diabetes Care achieved an impact factor of 17.152, the highest mark among journals devoted exclusively to original diabetes research. Diabetes Care and Diabetes are the top two journals publishing diabetes research, ranking second and fourth among the 146 journals in the broader field of endocrinology and metabolism.
Form 990, Part III, Line 4	Standards of Care in Diabetes Guidelines. For more than three decades, the ADA has published the Standards of Care in Diabetes Standards of Care the gold standard of diabetes clinical care guidance. In 2022, the Standards of Care reached more than three million professionals via journal publications and millions more via other ADA programs and channels. This year we worked to improve the processes, increase the methodological rigor, and engage even more experts to produce the 2023 edition, which came out in December 2022. Todays Standards of Care is more evidence based, more accessible, and more actionable than ever, helping clinicians around the world keep up with the rapidly changing health care landscape and drive better care, especially in communities disproportionately impacted by diabetes. Notable updates to the Standards of Care 2023 include Emphasis on supporting higher weight loss up to 15 based on the efficacy of and access to newer medications when appropriate. New recommendations related to sleep health and physical activity in people with diabetes. Broad consideration of social determinants of health in guiding the design and delivery of care. New hypertension diagnosis cut offs hypertension is now defined as a systolic blood pressure 130 mmHg or a diastolic blood pressure 80 mmHg. The expanded role of SGLT2 inhibitor use in preserved and reduced heart failure ejection fraction. The role of finerenone in individuals with diabetes and chronic kidney disease with albuminuria. New lipid management recommendations suggesting lower LDL goals for high-risk individuals.
Form 990, Part III, Line 4	The Standards of Care is available online and in print. We also offer an abridged version for primary care providers, an interactive app, plus continuing education webcasts and a slide deck for professional use. It is a living document, published annually in print and online and updated throughout the year in the form of online annotations and published addenda. Professional Papers and ReportsThe ADA published numerous papers and reports in 2022 to help people living with diabetes thrive, including Automated Insulin Delivery Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Continuous Glucose Monitoring Optimizing Diabetes Care Clinical Diabetes video series. Diabetes Management in Chronic Kidney Disease A Consensus Report by the American Diabetes Association ADA and Kidney Disease Improving Global Outcomes KDIGO. Health Equity and Diabetes Diabetes Spectrum collection. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association ADA and the European Association for the Study of Diabetes EASD. Optimizing the Use of Glucagon like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus Clinical Diabetes video series. Serious Later Risks Associated with Type 2 Diabetes in Adolescents and Young Adults Extended Observations From the TODAY Study Diabetes Care collection
Form 990, Part III, Line 4	Books and Compendia. In 2022, we added the following new editions to our library of professional books and clinical compendia 2022 2023 Guide to Medications for the Treatment of Diabetes Mellitus. John R. White, Jr., PA-C, PharmD Editor. ADA Clinical Compendium Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy. Rodica Pop-Busui, MD, PhD Editor. ADA Clinical Compendium New Evidence-Based Therapies for Complex Diabetic Foot Wounds. Andrew J.M. Boulton, MD, DSc Hon FACP, FRCP and David G. Armstrong, DPM, MD, PhD Editors. ADA Clinical Compendium A Practical Guide to Diabetes Related Eye Care. Thomas W. Gardner, MD, MS Editor. Annual Review of Diabetes 2022. American Diabetes Association. Medical Management of Type 1 Diabetes, 8th Edition. M. Sue Kirkland, MD Editor. Diabetes Core Update Podcast. Diabetes Core Update is a podcast series devoted to presenting and discussing the latest clinically relevant articles from the ADAs four scholarly journals Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum, as well as related content from other sources. In 2022, Diabetes Core Update reached an important milestone in podcasting one million downloads. Listeners can subscribe for free through mainstream podcast platforms or directly through diabetesjournals.org.
Form 990, Part III, Line 4	AWARENESS EDUCATION. American Diabetes Month Todays Diabetes Hits Different. November is American Diabetes Month ADM. Every year, our community comes together to ring the alarm on the diabetes epidemic. For the millions of us who are at risk for it, its a time to get educated, find resources and make sure all those around us are aware of their risk, too. And for the millions of us living with diabetes, its a chance to tell our stories and awaken the world. The theme for ADM in 2022 was Todays Diabetes Hits Different. Todays diabetes hits different. Different than it did even two years ago. Different risk factors and complications. Different communities, but it affects us all. Today, there are different ways to hit back. New technologies to manage diabetes. New public health policies. Better resources to educate ourselves. The ADAs 2022 ADM campaign, encouraged our audiences to share the current reality of diabetes and how they hit back. Everyones journey may be different, but it was time to highlight where weve been and how far weve come. With support from CVS Health, WeightWatchers, and Optum Store, we ran an integrated, multichannel campaign throughout November to help Americans know, share, make, and be the difference in our fight for better health with diabetes. It takes all of us to educate and inspire one another. Todays diabetes hits different, but our community people living with diabetes, those who care for them, and those who support the cause is stronger than ever before.
Form 990, Part III, Line 4	Campaign highlights 3.5M organic social media impressions, 118K social media engagements, 20K views of the ADM homepage, 27 livestreamed events, 612 media mentions 217.8M total potential reach. Focus on Diabetes. Focus on Diabetes FOD addresses the alarming prevalence of eye disease among people with diabetes about 95 percent of which is preventable. In 2022, together with our FOD Visionary Partners, Regeneron and VSP, the ADA increased education and awareness around the importance of routine comprehensive and dilated eye exams to prevent eye disease and vision loss caused by diabetes. Complementing our multi channel consumer awareness campaign were efforts to improve access to screening opportunities and type 2 diabetes risk testing. With the support of the VSP Eyes of Hope Mobile Clinic, community partner Ochsner Health, and local health and eye care professionals, the ADA hosted events in Lafayette and Baton Rouge, LA two communities substantially impacted by diabetes. There we provided no cost dilated eye exams, prescription eyewear, and eye health and diabetes education to 240 at risk constituents.
Form 990, Part III, Line 4	Through our strategic alliances, FOD increased engagement with optometrists, ophthalmologists, and primary care professionals by providing comprehensive education on diabetes related eye diseases. We also leveraged the expertise of a multi disciplinary team to develop FOD Provider Practice Toolkit, Diabetic Retinopathy Eye Health Guide, Eye Care Interprofessional Communication Protocol, A collaboration with and endorsed by the American Optometric Association, American Academy of Ophthalmology, American Society of Retina Specialists, National Eye Institute, and our Visionary Partners, A compendium A Practical Guide to Diabetes Related Eye Care. Supporters Regeneron Pharmaceuticals, Inc., VSP Vision. Know Diabetes by Heart. People living with type 2 diabetes are twice as likely to develop cardiovascular disease as people who do not have diabetes. Launched in 2018, Know Diabetes by Heart is a joint initiative between the ADA and American Heart Association AHA that aims to comprehensively combat the national public health impact of these intertwined diseases. The program turns ADA and AHA practice guidelines into lifelines by providing innovative resources for people with type 2 and targeted education for health care professionals. A total of 158,554 constituents accessed these resources this year.
Form 990, Part III, Line 4	In 2022, Know Diabetes by Heart Hosted 12 live Ask the Experts events for people with diabetes to discuss the relationship between diabetes, heart disease, and stroke. More than 6,000 people joined these sessions. Launched an interactive e learning opportunity to help people with diabetes learn about their risk and take action to prevent heart disease. Engaged with more than 4,000 health care professionals on guideline directed management and therapy. Through the ADAs quality improvement initiative, Diabetes INSIDE, worked with health care systems in Illinois, Maryland, New Jersey, and Pennsylvania to improve health care delivery and clinical outcomes for people with diabetes. Supporters Novo Nordisk, Bayer. ADA Camp. More than 18,000 children are diagnosed with type 1 diabetes every year, a life-changing moment that requires 24/7 control for the rest of their lives. For 74 years, ADA Camp has offered a traditional summer camp experience in a medically safe environment while creating opportunities for children with diabetes to forge life-long relationships, overcome feelings of isolation, and gain self confidence in their diabetes care. After two years of being online, our camps returned in person in 2022. More than 1,700 campers in 27 locations around the country joined in the summer fun, complete with swimming, fishing, kayaking, and the beauty of nature. With help from our partners, we award more than 430,000 in need-based financial assistance annually so even more children with type 1 have the chance to experience ADA Camp.
Form 990, Part III, Line 4	Year after year, the feedback from campers and families is overwhelming 78 of caregivers rated their childs overall health good or excellent, an increase of 22 from before camp. 82 of campers reported less than five days of poor mental health in a 30 day period after camp, a 20 decrease. 45 of caregivers reported that teamwork and communication improved within their family after camp. 41 of campers increased their confidence to try new methods to manage their diabetes. ADA Camp would not be possible without the support of Novo Nordisk Inc., The Leona M. and Harry B. Helmsley Charitable Trust, and Lilly Diabetes. Project Power. Youre never too young or old to lower your risk for type 2 diabetes and its complications. The ADAs Project Power aims to make living healthy second nature for both adults and kids living with prediabetes and type 2. For years, Project Power has aimed to slow the trajectory of childhood obesity and type 2 among youth aged 5 12. Using an outcomes based curriculum, the no cost virtual and in person program promotes making healthy food choices, increasing physical activity, and building family and peer support. In 2022, Project Power for youth grew to serve 27,605 children across more than 40 states.
Form 990, Part III, Line 4	And with the support of our national sponsors, in late 2022 we expanded Project Power to serve the whole family. Project Power for adults over 18 is a 12 month, no cost lifestyle change program that raises diabetes awareness and offers diabetes risk reduction education to people with type 2 diabetes and prediabetes. The program combines interactive lessons with a health coach, small support groups, and tools and resources to empower participants to reach their personal health goals. By 2024, we hope to serve 2,400 constituents in 24 high-risk areas through Project Power because healthy families mean healthy communities and ultimately a healthier world. Project Power was supported in 2022 by CVS, Eli Lilly, OneTouch by LifeScan, Sun Life Financial, and Quest Diagnostics. Diabetes Food Hub. Diabetes Food Hub continues to be a popular destination for people living with diabetes, caregivers, and health care professionals. In 2022, Diabetes Food Hub part recipe database, part grocery list builder, part meal planner, and 100 percent backed by the ADAs nutrition expertise grew by 17 percent. Its enewsletter now reaches over 350,000 subscribers with healthy recipes, cooking tips, and special content to help people cook more meals at home and shop safely in light of COVID19. Video content from our new live cooking class series in partnership with Homemade is now available on the site.
Form 990, Part III, Line 4	Better Choices for Life. Many consumer products and services make health claims, including preventing, managing, or even reversing diabetes and at times those claims can be both questionable and confusing. In March 2021, the ADA officially launched the Better Choices for Life program, designed to help shoppers make better choices while shopping for three product categories food and nutrition, health and wellness, and diabetes management. With its science and evidence based approach, Better Choices for Life provides a simple way to identify products and services that are suitable for people with or at risk for diabetes. Following an extensive evaluation process, companies applying for participation and passing the evaluation may place the Better Choices for Life mark on their packaging. Consumers can look for the mark to understand whether the products claims are supported by scientific evidence and meet the ADAs guidelines. As of 2022, participating companies include CeraVe, Cintas, Crest, Daiya, Egglife, Lavior, Level 2, Lean Cuisine, Listerine, Metamucil, Steel Blue, and Vicks products. What Can I Eat Program. The number one question we hear from people recently diagnosed with diabetes is, What can I eat To address this, in 2015 the ADA launched the What Can I Eat WCIE program to promote and sustain positive behavior changes related to healthy food choices.
Form 990, Part III, Line 4	In 2022 we completed development of the digital WCIE programs nine interactive nutrition education modules and supporting resources. In partnership with Elevance Health, we launched a multi state pilot program in Ohio, Indiana, New York, and Virginia. The program utilized Bento, a food company, to deliver healthy food boxes of items curated by ADA staff. We also trained coaches from community based organizations in local areas to provide program support. Combined, the digital modules and community support resources provide an interactive nutrition education experience, skill building activities, group support, and healthy food boxes in low income communities. Program enrollment began in late 2022. Signature Events. For the first time since February 2020, our signature events were conducted in person across the country, bringing together walkers, riders, and donors to raise critical funds for ADA programs and show their resounding support for all people living with diabetes. We also offered a virtual option, so anyone and everyone could participate. In 2022, 9,986 participants raised a total of 7,191,487 toward our mission. In the lead were Tour de Cure Wine Country, raising over 1.3 million, and Step Out Walk to Stop Diabetes Pittsburgh, which raised 227,590. Another event highlight was the 20th annual Kiss a Pig Gala, held in Bentonville, AR. With over 700 attendees, Kiss a Pig is the most-attended charity gala in the state and the largest ADA gala in the country. The October 2022 event successfully raised over 1.4 million the most in Kiss a Pig history.
Form 990, Part III, Line 4	ADVOCACY. Speaking Up for All People with Diabetes. The ADAs advocacy efforts and achievements are at the core of creating effective and lasting change for people living with and at risk for diabetes. Our advocacy work gives people with diabetes, their families, and health care professionals the power to influence public policy issues that affect people with diabetes at the local, state, and national levels. Our primary goals are To increase federal and state funding for diabetes prevention, treatment, and research. To prevent diabetes. To improve the availability of accessible, adequate, and affordable health care. To end the discrimination people with diabetes face at school, work, and elsewhere in their lives. 2022 was a landmark year for diabetes advocacy, with the ADA leading the charge for groundbreaking policies that will improve the lives of the over 133 million Americans living with diabetes and prediabetes. From Capitol Hill to state capitals across the country, our more than 400,000 Diabetes Advocates devoted their efforts to supporting and advancing critical ADA-sponsored legislation and diabetes prevention policies. United in a common goal against this pervasive disease, the ADA continues to work endlessly to implement impactful policy reforms aimed towards bending the curve and promoting a healthier future for diabetes patient communities.
Form 990, Part III, Line 4	Making Diabetes Care More Affordable. Managing diabetes can be financially devastating, dually impacting patients and members of their support system. As more Americans are burdened with rising out of pocket costs, many find themselves skipping care and rationing medications just to make ends meet. While we understand these methods adversely impact treatment plans, this has become the harsh reality for millions of patients struggling with diabetes. In 2022, the ADA worked tirelessly to ensure diabetes treatments are widely accessible and affordable for the American population. Our commitment to advocacy Ushered in the passage of landmark federal legislation limiting the monthly cost of lifesaving insulin to 35 for Americas seniors on Medicare. Yielded policies that capped annual out of pocket costs for seniors on Medicare at no more than 2,000. Ensured premium subsidies for those on Affordable Care Act health insurance plans would continue through 2025. Enacted monthly cost sharing caps on insulin for people with state regulated plans in 22 states, plus the District of Columbia. Prompted Delaware to sign a law capping diabetes equipment and supply costs at a collective 35 per month.
Form 990, Part III, Line 4	Lowering Barriers to Diabetes Technology. Health insurance systems, including Medicare and Medicaid, often have restrictive policies that make it difficult for people to access diabetes-management devices, which have been shown to tremendously improve diabetes outcomes. The ADA recognizes that people who could benefit most from CGMs those with lower incomes, people on Medicaid, and elderly people of color who live in states with the highest rates of diabetes prevalence and mortality are the least likely to have access to this technology. Throughout 2022, the ADA managed to increase access to diabetes technology, and CGMs in particular, at both the federal and state levels. Our concerted advocacy efforts, aimed at the Centers for Medicare and Medicaid, the U.S. Department of Veterans Affairs, and state Medicaid programs and legislatures, resulted in proposed regulations for these federal programs and improvements in Medicaid coverage in more than 10 states. Preventing Amputations. Every three and a half minutes, someone in America undergoes a diabetes-related limb amputation. Sadly, 85 percent of these amputations are preventable, with most occurring among people of color, particularly those with less access to care.
Form 990, Part III, Line 4	In response to these startling amputation statistics, in 2022 the ADA proactively formed an alliance with leading health organizations, professional groups, clinical experts, policymakers, and leaders in the diabetes community, aimed at preventing diabetes related amputations. The Amputation Prevention Alliances APAs overarching mission is to curb the number of amputations among low income and minority individuals with diabetes. Guided by a Clinical Advisory Working Group, the APAs multi-faceted work will include advancing impactful and targeted policy changes, driving clinician awareness of opportunities to prevent amputations, and empowering patients to advocate for the best care. While these reforms will undoubtedly yield a decrease in amputations overall, the ADA will continue to fight to save both limbs and lives. Increased Funding for Diabetes Research and Prevention Programs. Under widespread financial uncertainty, the ADA was successful in increasing federal funding for diabetes research and prevention programs. The National Institutes of Health, the NIDDK, the CDC Division of Diabetes Translation, and the National DPP all received substantial funding increases in 2022. These increases augment vital programs that develop groundbreaking treatments and potential cures for diabetes.
Form 990, Part III, Line 4	Safer Schools for Students with Diabetes. The ADAs Safe at School campaign works to make sure the diabetes management needs of children are met so they are healthy, safe, and able to enjoy the same opportunities as their peers. This campaign maintains a commitment to challenging discriminatory practices and policies on behalf of the nations youth and fostering a healthier learning environment for patients battling the effects of this chronic disease. Historically, New York City Public Schools have failed to meet their legal obligations and provide appropriate accommodations for students with diabetes. Our organization believes students with diabetes deserve to attend school alongside their peers, free from discrimination. In response to these inequities, the ADA filed a lawsuit against the New York City Department of Education and won a settlement in September 2022. Thanks to these efforts, NYC public school students with diabetes now have improved access to diabetes care during the school day and can safely participate in field trips and school sponsored events. We aspire to use this ruling as a model for school districts across the nation.
Form 990, Part III, Line 4	Were Connected for Life. The ADA is the nations leading voluntary health organization fighting to bend the curve on the diabetes epidemic to help people live a better life and thrive until we ultimately find a cure. Diabetes has brought us all together, what we do next makes us Connected for Life. We have a lot to accomplish in 2023, but with our dedicated family of volunteers, advocates, donors, staff, and board members we will continue to make an impact for people with and at risk for diabetes. Learn more about the American Diabetes Association at diabetes.org.
Form 990, Part III, Line 4	Other Program Services revenue reported in Line 4d 1,881,739 relates to the investment in real estate. This investment represents a 1998 donor bequest that restricted the ADA from selling the property for 25 years. A portion of the property is leased to corporations and derives monthly income that is reported in investment income. 108,750 relates to rental income received from tenants of subleased office space.
Form 990, Part VI, Section A, Line 6,7a	The American Diabetes Association has established the voting membership of the ADA as the Voting Members. The Voting Members are comprised of all of the members of the Board of Directors and additional delegates. The Voting Members vote on the election of the organizations governing body each year. No governance decisions are reserved to or subject to approval by the membership.
Form 990, Part VI, Section B, Line 11	IRS Review Process by the Governing Body The American Diabetes Association Board of Directors assigns the Audit Committee the oversight responsibility of the IRS Form 990 and its supplemental schedules prior to completion. After review by management and BDO, the final signed 990 was provided to the ADAs Board of Directors prior to filing with the IRS.
Form 990, Part VI, Section B, Line 12	Managing Conflict of Interest To identify potential conflicts of interest with appropriate due diligence, Officers, Directors, and members of select Board appointed committees and their related subcommittees, journal/periodical editors, and senior staff of the ADA must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit Committee and senior staff in Legal Affairs manage the disclosure and monitoring processes. Through review of the annual disclosures and review of the agendas of the relevant Board ,Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting. Based on the situation, senior volunteers and staff presiding over the discussion are responsible to ensure appropriate action is taken for the individual to publicly disclose the conflict, for the individual to recuse him or herself from the discussion, vote or room as appropriate and to ensure the disclosure and action is documented in the minutes of the meeting.
Form 990, Part VI, Section B, Line 15a	Compensation Process Annually, The American Diabetes Association Principal Officers Chair of the Board President, Medicine Science President, Health Care Education and Secretary/Treasurer are responsible for establishing executive compensation consistent with the guidelines approved by the Compensation Committee. The Principal Officers of the ADA use a Compensation Committee, compensation studies and an in dependent consultant to establish the compensation of the Chief Executive Officer and other Key employees. The Chief Executive Officer is responsible for the individual performance evaluations of staff officers and key employees, and establishes the total compensation for key employees subject to the guidelines established by the Executive Compensation Committee. The Executive Compensation Committee develops guidelines for the key employee executive positions listed below following the process described in the IRS intermediate sanctions rules when determining compensation. Specifically, the Committee 1 Is composed entirely of non-employee volunteer leaders who have no familial, business or significant personal relationships with the American Diabetes Association or its executives 2 Assesses the short-term and long-term contribution and performance of CEO and other senior executive employees in meeting very definitive and quantifiable objectives focused on the ADAs mission success 3 Engages an independent compensation consulting firm to compile appropriate comparability data including compensation market information for peers with whom the American Diabetes Association competes for executive talent. 4 The Committee reviews this data in detail for all elements of each executives total compensation, including but not limited to base salary, bonuses, perquisites, fringe benefits, and incentive and deferred compensation arrangements. Upon the executives hire, and at each point in time thereafter at which a new or revised compensation arrangement is under consideration with respect to the executive, the Committee meets before the arrangement is implemented to evaluate the reasonableness of the arrangement by comparing both the arrangement itself and the executives entire compensation package to compensation packages paid by similarly situated organizations for functionally comparable positions 5 Documents, concurrently with its determination, the basis for its determination in the minutes of its meeting These minutes are reviewed, revised if necessary and approved at the following meeting of the Executive Compensation Committee. The process described above was used to establish compensation for the following positions Chief Executive Officer, Chief Development Officer, Chief Financial and Administrative Officer, Chief Scientific and Medical Officer, Chief Operating and Strategy Officer, Chief Advocacy Officer, Senior Vice President and Chief Technology Officer, Senior Vice President of Human Resources, Chief Marketing and Digital Officer. The total compensation of executives at the American Diabetes Association is specifically designed to attract and retain the highest qualified executive talent to fulfill the critically important mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
Form 990, Part VI, Section C, Line 17	Filing Jurisdiction Registration Number Alabama-AL97-256, Alaska-N/A, Arizona-10145, Arkansas-N/A, California-CT81471, Colorado-2002-3003670, Connecticut-5084, District of Columbia-981855, Florida-CH1618, Georgia-CH-001422, Hawaii-N/A, Illinois-CO 01-025537, Indiana-000103829-000, Kansas- 177-257-3SO, Kentucky-45, Louisiana-N/A, Maine- CO-1247, Maryland-102, Massachusetts-029317, Michigan-MICS 10326, Minnesota-N/A, Mississippi- 100000294, Missouri- CO-021-87, New Hampshire-5006, New Jersey- CH-0581900, New Mexico-N/A, New York- 1/30/1965, North Carolina- SL000618, North Dakota-7894, Ohio- 01-0239, Oklahoma- N/A, Oregon- 16402, Pennsylvania- No. 21, Rhode Island-95-233, South Carolina-641, Tennessee-5104, Utah- 6536093-Char, Virginia-N/A, Washington-7664, West Virginia-N/A, Wisconsin- 3020-800.
Form 990, Part VI, Section C, Line 19	The following information is available on the American Diabetes Associations website http//www.diabetes.org Board of Directors, Audited Consolidated Financial Statements, Latest 990 filed, Whistleblower policy. Available subject to request to the American Diabetes Association Legal Affairs department are the following Current Bylaws, Articles of Incorporation, Conflict of Interest Policy.
Form 990, Part VII, Section A, Line 1a1	The Chief Executive Officer of the ADA is a non-voting member of the Board of Directors.
Form 990, Part IX, Line 11g	Other fees for services include the following Total ExpensesProgram Service ExpensesManagement and General ExpensesFundraising ExpensesProgram consulting fees 12,333,397.00 12,333,397.00 0.00 0.00 Other fees for services 4,317,194.00 2,504,900.00 588,507.00 1,223,787.00 Total16,650,591.00 14,838,297.00 588,507.00 1,223,787.00
Form 990, Part VI, Section B, Line 12c	Research Grants Review Committee Conflict of Interest COI within the Research Grants Review Committee is managed through a written COI policy and through COI declarations signed both before and after the review cycle. The COI for grant reviewers is self reported. The primary considerations addressed in the COI policy and program guidelines are as follows Institutional Individuals are required to recuse themselves from reviewing grants for scientists at the same institution, including any institutions with which they may be negotiating employment. Financial Individuals are required to recuse themselves from reviewing grants from which they stand to gain financially if the grant is awarded co PI, collaborator, subcontracts, etc.. Personal Individuals are required to recuse themselves from reviewing grants for investigators with whom they either have a personal or professional relationship collaborators, colleagues or personal friends, or a long standing professional or scientific disagreement that prevents them from unbiased review.
Form 990, Part VII, Section A, Line 1-23	Average hours per week is estimated based on meeting attendance and other ADA activities performed throughout the year.
Form 990, Part I, Line 8	Contributions and grants reported on the 2021 Form 990 included forgiveness of Paycheck Protection Program Loans in the amount of 10,321,000.

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990) 2021

Additional Data

Software ID:	22015461
Software Version:	22.0.1.0

1	Briefly describe the organization’s mission or most significant activities: The mission of the American Diabetes Association the Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
2	Check this box
3	Number of voting members of the governing body (Part VI, line 1a) ........	3	13
4	Number of independent voting members of the governing body (Part VI, line 1b) .....	4	13
5	Total number of individuals employed in calendar year 2021 (Part V, line 2a) ......	5	394
6	Total number of volunteers (estimate if necessary) .............	6	7,910
7a	Total unrelated business revenue from Part VIII, column (C), line 12 ........	7a	805,283
b	Net unrelated business taxable income from Form 990-T, Part I, line 11 .........	7b

		Prior Year	Current Year
8	Contributions and grants (Part VIII, line 1h) .........	113,184,567	93,952,438
9	Program service revenue (Part VIII, line 2g) .........	16,969,473	19,576,892
10	Investment income (Part VIII, column (A), lines 3, 4, and 7d ) ....	2,309,537	495,586
11	Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)	5,702,144	5,117,087
12	Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)	138,165,721	119,142,003
13	Grants and similar amounts paid (Part IX, column (A), lines 1–3 )...	8,161,453	23,200,708
14	Benefits paid to or for members (Part IX, column (A), line 4).....		0
15	Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)	30,224,262	35,639,110
16a	Professional fundraising fees (Part IX, column (A), line 11e) .....	585,277	629,915
b	Total fundraising expenses (Part IX, column (D), line 25) 18,124,878
17	Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e)....	42,841,703	53,104,745
18	Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25)	81,812,695	112,574,478
19	Revenue less expenses. Subtract line 18 from line 12.......	56,353,026	6,567,525
		Beginning of Current Year	End of Year
20	Total assets (Part X, line 16).............	186,412,830	213,679,073
21	Total liabilities (Part X, line 26).............	29,672,159	56,658,901
22	Net assets or fund balances. Subtract line 21 from line 20.....	156,740,671	157,020,172

Sign Here

	Signature of officer	Date

	Type or print name and title


4a	(Code: ) (Expenses $ 39,781,741 including grants of $ 923,963 ) (Revenue $ 10,290,031 )
	Information - See Schedule O

4b	(Code: ) (Expenses $ 14,319,220 including grants of $ 3,989 ) (Revenue $ )
	Advocacy and Public Awareness - See Schedule O

4c	(Code: ) (Expenses $ 32,637,257 including grants of $ 22,272,756 ) (Revenue $ 10,768,198 )
	Research - See Schedule O

4d	Other program services (Describe in Schedule O.)
	(Expenses $ including grants of $ ) (Revenue $ 1,881,739 )
4e	Total program service expenses86,738,218

(A) Name and title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)	(D) Reportable compensation from the organization (W-2/1099-MISC/1099-NEC)	(E) Reportable compensation from related organizations (W-2/1099-MISC/1099-NEC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and title
(18) Mandeep Bajaj MBBS........................................................................ Board of Directors	1.00 .......................	X	0	0	0
(19) Amparo Gonzalez MPH RN CDE FAADE........................................................................ Board of Directors	1.00 .......................	X	0	0	0
(20) Rhodes B Ritenour JD........................................................................ Board of Directors	1.00 .......................	X	0	0	0
(21) Stephanie E Silverman MBA Through J........................................................................ Board of Directors	1.00 .......................	X	0	0	0
(22) Ruth Weinstock MD PhD........................................................................ Board of Directors	1.00 .......................	X	0	0	0
(23) Robin Richardson Effective June 4 2........................................................................ Board of Directors	1.00 .......................	X	0	0	0

1b	Sub-Total................
c	Total from continuation sheets to Part VII, Section A....
d	Total (add lines 1b and 1c)...........	2,782,371	413,128

1a	Federated campaigns..		1a	2,103,543
b	Membership dues..		1b
c	Fundraising events..		1c	8,780,964
d	Related organizations		1d
e	Government grants (contributions)		1e	1,566,205

f	All other contributions, gifts, grants, and similar amounts not included above		1f	81,501,726

g	Noncash contributions included in lines 1a - 1f:$		1g	4,040,659

h Total. Add lines 1a-1f.......		93,952,438

		Business Code
2a	Subscriptions	511120	6,690,226	6,690,226
b	Registration	611710	7,895,097	7,895,097
c	Sales of Material	511130	533,043	533,043
d	Booth Rental	611710	3,480,289		3,480,289
e	Other Program Service Revenue	900099	978,237	978,237
f	All other program service revenue.
g	Total. Add lines 2a–2f .....		19,576,892

3 Investment income (including dividends, interest, and othersimilar amounts) ......			1,748,594			1,748,594
4 Income from investment of tax-exempt bond proceeds
5 Royalties...........			1,754,011			1,754,011
		(ii) Personal	(i) Real
6a	Gross rents			6a
b	Less: rental expenses			6b
c	Rental income or (loss)			6c
d	Net rental income or (loss).......
		(ii) Other	(i) Securities
7a	Gross amount from sales of assets other than inventory	47,048	908,987	7a
b	Less: cost or other basis and sales expenses	52,028	2,157,015	7b
c	Gain or (loss)	-4,980	-1,248,028	7c
d	Net gain or (loss).........			-1,253,008			-1,253,008
8a	Gross income from fundraising events (not including $ 8,780,964of contributions reported on line 1c). See Part IV, line 18 ....
			8a	1,515,662
b	Less: direct expenses ...		8b	1,515,662
c	Net income or (loss) from fundraising events..
9a	Gross income from gaming activities. See Part IV, line 19 ...
			9a
b	Less: direct expenses ...		9b
c	Net income or (loss) from gaming activities..
10a	Gross sales of inventory, less returns and allowances ..
			10a
b	Less: cost of goods sold ..		10b
c	Net income or (loss) from sales of inventory..
Business Code			Miscellaneous Revenue
11a	Advertising Income		541800	800,815		800,815
b	Catalog Sales Income - Gift of Hope		454110	4,468		4,468
c	Abstract Fees Permissions Income		900099	625,608	625,608
d	All other revenue ....			1,932,185	1,932,185
e	Total. Add lines 11a–11d ......			3,363,076
12	Total revenue. See instructions.....			119,142,003	18,654,396	805,283	5,729,886

1	Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21 ....	23,151,755	23,151,755
2	Grants and other assistance to domestic individuals. See Part IV, line 22 ...........	48,953	48,953
3	Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, lines 15 and 16. .............	0
4	Benefits paid to or for members .......	0
5	Compensation of current officers, directors, trustees, and key employees ...........	3,195,498	2,091,137	416,126	688,235
6	Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) .........	0
7	Other salaries and wages........	25,981,975	16,998,826	3,376,810	5,606,339
8	Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) ....	218,929	144,096	27,795	47,038
9	Other employee benefits .......	4,104,750	2,646,530	619,280	838,940
10	Payroll taxes ...........	2,137,958	1,401,238	268,832	467,888
11	Fees for services (non-employees):
a	Management ......	0
b	Legal .........	230,250	30,340	186,481	13,429
c	Accounting ...........	256,495	5,131	250,082	1,282
d	Lobbying ...........	254,876	254,876
e	Professional fundraising services. See Part IV, line 17	629,915			629,915
f	Investment management fees ......	209,874		209,874
g	Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O)	16,650,591	14,838,297	588,507	1,223,787
12	Advertising and promotion ....	4,794,457	2,069,431	4,388	2,720,638
13	Office expenses .......	1,043,192	630,733	195,473	216,986
14	Information technology ......	3,518,167	2,320,413	341,822	855,932
15	Royalties ..	27,554	27,482		72
16	Occupancy ...........	4,863,388	3,648,715	436,263	778,410
17	Travel ............	943,156	758,041	55,610	129,505
18	Payments of travel or entertainment expenses for any federal, state, or local public officials .	0
19	Conferences, conventions, and meetings ....	5,862,252	5,831,966	2,525	27,761
20	Interest ...........	35	9	5	21
21	Payments to affiliates .......	0
22	Depreciation, depletion, and amortization ..	2,213,675	1,438,889	287,778	487,008
23	Insurance ...	375,694	271,077	38,814	65,803
24	Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a	Supplies	2,539,491	2,473,763	22,373	43,355
b	Postage and Shipping	1,901,810	779,994	11,382	1,110,434
c	Printing and Publications	3,974,793	2,580,462	20,568	1,373,763
d	Data Processing	3,387,620	2,274,261	330,513	782,846
e	All other expenses	57,375	21,803	20,081	15,491
25	Total functional expenses. Add lines 1 through 24e	112,574,478	86,738,218	7,711,382	18,124,878
26	Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).	10,477,505	2,198,410	99,003	8,180,092

1	Cash–non-interest-bearing ........			874,746	1	216,475
2	Savings and temporary cash investments .........			39,642,647	2	60,857,512
3	Pledges and grants receivable, net ......			54,877,293	3	52,564,508
4	Accounts receivable, net .............			1,464,766	4	1,262,632
5	Loans and other receivables from any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .......
					5
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), and persons described in section 4958(c)(3)(B) ...
					6
7	Notes and loans receivable, net ...........				7
8	Inventories for sale or use ............			296,086	8	336,906
9	Prepaid expenses and deferred charges ......			2,248,439	9	3,147,397
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	27,247,020
b	Less: accumulated depreciation	10b	23,007,124	5,587,220	10c	4,239,896
11	Investments—publicly traded securities .			49,367,410	11	44,330,366
12	Investments—other securities. See Part IV, line 11 .....			12,516,775	12	11,104,921
13	Investments—program-related. See Part IV, line 11 ..				13
14	Intangible assets ...............				14
15	Other assets. See Part IV, line 11 ...........			19,537,448	15	35,618,460
16	Total assets. Add lines 1 through 15 (must equal line 33)...			186,412,830	16	213,679,073

17	Accounts payable and accrued expenses .....	18,310,089	17	8,070,665
18	Grants payable ...	3,903,387	18	15,768,715
19	Deferred revenue .........	7,458,683	19	5,613,331
20	Tax-exempt bond liabilities .........		20
21	Escrow or custodial account liability. Complete Part IV of Schedule D		21
22	Loans and other payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .........
			22
23	Secured mortgages and notes payable to unrelated third parties ..		23
24	Unsecured notes and loans payable to unrelated third parties ..		24
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17 - 24). Complete Part X of Schedule D		25	27,206,190
26	Total liabilities. Add lines 17 through 25..	29,672,159	26	56,658,901

	Organizations that follow FASB ASC 958, check here and complete lines 27, 28, 32, and 33.
27	Net assets without donor restrictions ..........	58,558,684	27	53,866,582
28	Net assets with donor restrictions ...........	98,181,987	28	103,153,590
	Organizations that do not follow FASB ASC 958, check here and complete lines 29 through 33.
29	Capital stock or trust principal, or current funds .....		29
30	Paid-in or capital surplus, or land, building or equipment fund ...		30
31	Retained earnings, endowment, accumulated income, or other funds		31
32	Total net assets or fund balances ...........	156,740,671	32	157,020,172
33	Total liabilities and net assets/fund balances ........	186,412,830	33	213,679,073

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	(g) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	Yes	No
(1)American Diabetes Association Property Title Holding Corporation 2451 Crystal Drive Ste 900 Arlington,VA22202 54-1948004	See Part VII	VA	501 c 2	N/A	Association	Yes

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?		(k) Percentage ownership
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No	(k) Percentage ownership

(a) Name of related organization	(b) Transaction type (a-s)	(c) Amount involved	(d) Method of determining amount involved
(1) American Diabetes Association Property Title Holding Corporation	b	57,375	Cash
(2) American Diabetes Association Property Title Holding Corporation	s	1,772,989	Cash

(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(e) Are all partners section 501(c)(3) organizations?		(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?		(k) Percentage ownership
(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	Yes	No	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No	(k) Percentage ownership